George A. Bray | Academic Influence

Q: What Schools Are Affiliated With George A. Bray

George A. Bray is affiliated with the following schools: Université Laval, Brown University, University of Kentucky, Louisiana State University, University of Southern California, Georgetown University, University of Washington, Columbia University, University of Massachusetts

Why Is George A. Bray Influential?

(Suggest an Edit or Addition)

According to Wikipedia, George A. Bray is an American obesity researcher. As of 2016, he is a University Professor emeritus and formerly the chief of the division of clinical obesity and metabolism at Louisiana State University's Pennington Biomedical Research Center in Baton Rouge. He is also a Boyd Professor emeritus at the Pennington Center, and a professor of medicine emeritus at the Louisiana State University Medical Center.

(See a Problem?)

George A. Bray's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Obesity : Preventing and managing the global epidemic (2000) (16983)
A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter (1960) (6866)
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. (1997) (5351)
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet (2001) (3518)
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism (2006) (2507)
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. (2004) (1904)
Obesity (2008) (1836)
Medical consequences of obesity. (2004) (1686)
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. (2001) (1589)
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (2013) (1520)
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes (2007) (1502)
Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. (2009) (1468)
Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk (2010) (1346)
Dietary fat intake does affect obesity! (1998) (1186)
Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes (2010) (1105)
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss (2006) (1069)
Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. (1979) (1057)
Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. (2004) (983)
Fast-food consumption among US adults and children: dietary and nutrient intake profile. (2003) (823)
Pioglitazone for diabetes prevention in impaired glucose tolerance. (2011) (661)
Handbook of obesity (1997) (657)
A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. (2005) (629)
The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. (1999) (625)
American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. (2015) (607)
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. (2001) (596)
Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial (2001) (593)
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. (2011) (579)
Effects of obesity on respiratory function. (1983) (567)
Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. (2001) (564)
Differential oxidation of individual dietary fatty acids in humans. (2000) (549)
Endocrine and metabolic effects of experimental obesity in man. (1973) (532)
Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. (2003) (528)
The Zucker-fatty rat: a review. (1977) (520)
Achieving weight and activity goals among diabetes prevention program lifestyle participants. (2004) (517)
Obesity (2017) (504)
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. (2015) (497)
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity (2008) (490)
The Relationship of Waist Circumference and BMI to Visceral, Subcutaneous, and Total Body Fat: Sex and Race Differences (2011) (473)
Sex, race/ethnicity, socioeconomic status, and BMI in relation to self-perception of overweight. (2002) (457)
The Science of Obesity Management: An Endocrine Society Scientific Statement. (2018) (453)
Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. (2005) (440)
Epidemiology, trends, and morbidities of obesity and the metabolic syndrome (2006) (440)
Complications of obesity. (1985) (436)
Medicinal strategies in the treatment of obesity (2000) (429)
The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults (2002) (426)
FGF21 is an endocrine signal of protein restriction. (2014) (407)
Low serum testosterone and sex-hormone-binding-globulin in massively obese men. (1977) (403)
Management of obesity (2016) (402)
Sibutramine produces dose-related weight loss. (1999) (389)
Definition, measurement, and classification of the syndromes of obesity. (1978) (364)
Dietary fat and obesity: a review of animal, clinical and epidemiological studies (2004) (353)
The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. (2000) (349)
Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study (2012) (345)
Genetically transmitted obesity in rodents. (1971) (342)
A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. (2003) (329)
Current and potential drugs for treatment of obesity. (1999) (321)
Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes? (2014) (315)
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. (2016) (312)
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. (2016) (308)
Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial. (2002) (304)
Recent Advances in Obesity Research (1979) (298)
Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. (1991) (292)
Effect of obesity on bioelectrical impedance. (1989) (283)
Obesity as a Disease: A White Paper on Evidence and Arguments Commissioned by the Council of The Obesity Society (2008) (282)
Overweight Is Risking Fate (1984) (276)
Adipose tissue collagen VI in obesity. (2009) (273)
Lifestyle change and mobility in obese adults with type 2 diabetes. (2012) (272)
Pathophysiology of obesity. (1992) (270)
Hunger : basic mechanisms and clinical implications (1976) (269)
Healthy Eating Index and obesity (2004) (268)
Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. (1988) (267)
Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. (2002) (265)
Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. (2004) (258)
Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial. (2012) (250)
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. (2008) (249)
The Prader‐Willi Syndrome: A Study of 40 Patients and a Review of the Literature (1983) (247)
Council on Nutrition, Physical Activity, and Metabolism Statement on Obesity and Heart Disease From the Obesity Committee of the Weight Loss: An Update of the 1997 American Heart Association Scientific Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of (2006) (245)
Afferent signals regulating food intake (2000) (243)
Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. (1991) (235)
Validity of the Remote Food Photography Method (RFPM) for Estimating Energy and Nutrient Intake in Near Real‐Time (2012) (228)
The underlying basis for obesity: relationship to cancer. (2002) (222)
Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial. (2016) (221)
A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. (2004) (220)
MANIFESTATIONS OF HYPOTHALAMIC OBESITY IN MAN: A COMPREHENSIVE INVESTIGATION OF EIGHT PATIENTS AND A EEVIEW OF THE LITERATURE (1975) (219)
Reproductive hormonal function in the genetically obese (ob/ob) mouse. (1976) (218)
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association (2015) (217)
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans (2019) (214)
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. (2014) (211)
Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study. (1996) (208)
Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. (1989) (207)
Basic and clinical aspects of regional fat distribution. (1990) (207)
Racial differences in abdominal depot-specific adiposity in white and African American adults. (2010) (206)
The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. (2002) (205)
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. (2003) (204)
The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. (2004) (201)
Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. (2005) (198)
A dietary approach to prevent hypertension: A review of the dietary approaches to stop hypertension (DASH) study (1999) (197)
Treatment of obesity: an overview. (1988) (197)
Obesity and reproduction. (1997) (196)
A double-blind randomized placebo-controlled trial of sibutramine. (1996) (196)
Assessment of energy intake underreporting by doubly labeled water and observations on reported nutrient intakes in children. (1998) (193)
Effect of caloric restriction on energy expenditure in obese patients. (1969) (192)
Neuroendocrine control of the development of obesity : understanding gained from studies of experimental animal models (1990) (192)
The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. (1977) (190)
Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. (1995) (188)
Use and Abuse of Appetite-Suppressant Drugs in the Treatment of Obesity (1993) (186)
Health hazards of obesity. (1996) (185)
The association of body weight, dietary intake, and energy expenditure with dietary restraint and disinhibition. (1995) (183)
Energy and Fructose From Beverages Sweetened With Sugar or High-Fructose Corn Syrup Pose a Health Risk for Some People12 (2013) (177)
Acetylation alters the feeding response to MSH and beta-endorphin (1989) (177)
Is 5% weight loss a satisfactory criterion to define clinically significant weight loss? (2015) (173)
Overweight is risking fate. Definition, classification, prevalence, and risks. (1987) (170)
Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial. (2005) (170)
Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. (2006) (170)
Association of Body Mass with Dietary Restraint and Disinhibition (1995) (169)
Pharmacological Treatment of the Overweight Patient (2007) (169)
Diurnal Variation in Glucose Tolerance: Cyclic Suppression of Insulin Action and Insulin Secretion in Normal-Weight, But Not Obese, Subjects (1992) (169)
METABOLIC INTERACTIONS BETWEEN L‐ASCORBIC ACID AND DRUGS (1961) (168)
Clinical review 90: Leptin and clinical medicine: a new piece in the puzzle of obesity. (1997) (168)
Obesity. Part I--Pathogenesis. (1988) (167)
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors’ Expert Forum (2015) (167)
American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. (2014) (166)
North-American Twins With IDDM: Genetic, Etiological, and Clinical Significance of Disease Concordance According to Age, Zygosity, and the Interval After Diagnosis in First Twin (1993) (165)
Obesity: a time bomb to be defused (1998) (164)
The MONA LISA hypothesis in the time of leptin. (1998) (164)
Impact of Intensive Lifestyle Intervention on Depression and Health-Related Quality of Life in Type 2 Diabetes: The Look AHEAD Trial (2014) (163)
Family History of Diabetes Links Impaired Substrate Switching and Reduced Mitochondrial Content in Skeletal Muscle (2007) (162)
A short history of beverages and how our body treats them (2008) (160)
The thermic effect of food and obesity: a critical review. (1997) (159)
Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. (2012) (159)
Classification and evaluation of the obesities. (1989) (159)
Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications (2000) (155)
Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program (2008) (155)
The prevention of type 2 diabetes (2008) (155)
Evaluation of body fat in fatter and leaner 10-y-old African American and white children: the Baton Rouge Children's Study. (2001) (153)
The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. (1999) (152)
Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. (2010) (150)
Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes (2014) (149)
Beyond energy balance: there is more to obesity than kilocalories. (2005) (148)
Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study (2006) (143)
Increased sensitivity of the thyroid in iodine-depleted rats to the goitrogenic effects of thyrotropin. (1968) (142)
Obesity is a chronic, relapsing neurochemical disease (2004) (140)
Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity. (1988) (139)
Enterostatin (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase, selectively reduces fat intake (1991) (138)
An enzymatic defect in the obese (ob/ob) mouse: loss of thyroid-induced sodium- and potassium-dependent adenosinetriphosphatase. (1978) (138)
HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and -independent mechanisms. (2009) (138)
Ventromedial hypothalamus modulates fat mobilisation during fasting (1978) (137)
Dependence of hypothalamic obesity on insulin, the pituitary and the adrenal gland. (1972) (136)
How bad is fructose? (2007) (136)
Risks of obesity. (2003) (134)
Ventromedial hypothalamic lesions and the mobilization of fatty acids. (1978) (132)
Relationship between obesity, weight loss, and taste responsiveness (1976) (132)
Some effects of adrenalectomy in the fatty rat. (1978) (129)
Prediction of body fat in 12-y-old African American and white children: evaluation of methods. (2002) (128)
Calorie‐sweetened beverages and fructose: what have we learned 10 years later (2013) (127)
Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. (2001) (126)
Lifestyle and pharmacological approaches to weight loss: efficacy and safety. (2008) (125)
Sugar Sweetened Beverages , Obesity , Type 2 Diabetes and Cardiovascular Disease risk (2010) (124)
A concise review on the therapeutics of obesity. (2000) (123)
Handbook of obesity : etiology and pathophysiology (2004) (123)
Dietary Fat Preferences Are Inversely Correlated with Peripheral Gustatory Fatty Acid Sensitivity a (1998) (123)
An approach to the classification and evaluation of obesity. (1992) (122)
Soft drink consumption and obesity: it is all about fructose (2010) (120)
Handbook of obesity : clinical applications (2003) (116)
Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. (2011) (116)
Drug treatment of the overweight patient. (2007) (116)
Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program (2007) (115)
Effects of Tyrosine, Phentermine, Caffeine d-amphetamine, and Placebo on Cognitive and Motor Performance Deficits During Sleep Deprivation (2003) (114)
Studies on food intake of genetically obese rats. (1972) (114)
Use of anthropometric measures to assess weight loss. (1978) (113)
Relationship between resting metabolic rate and the composition of the fat-free mass. (1997) (113)
Potential Health Risks From Beverages Containing Fructose Found in Sugar or High-Fructose Corn Syrup (2012) (112)
Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular brown adipose tissue (1990) (110)
Medical Therapy for the Patient With Obesity (2012) (108)
Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study (2018) (107)
Ventilatory responses to the metabolic acidosis of treadmill and cycle ergometry. (1976) (106)
Effect of Dietary Sodium Intake on Blood Lipids: Results From the DASH–Sodium Trial (2004) (106)
Weight loss and blood pressure control (Pro). (2008) (105)
Effect of topiramate on body weight and body composition of osborne-mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs. (2000) (105)
Obesity: historical development of scientific and cultural ideas. (1990) (105)
Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study (2001) (105)
Sympathetic nerve activity after discrete hypothalamic injections of l-glutamate (1993) (104)
Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake (1991) (103)
Sibutramine: a novel new agent for obesity treatment. (1995) (102)
Differential inhibition of fat intake in two strains of rat by the peptide enterostatin. (1992) (102)
Validity and reliability of reported dietary intake data. (1994) (102)
Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial (2018) (98)
Resistance Versus Aerobic Exercise Acute effects on glycemia in type 1 diabetes (2012) (97)
Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity (1994) (97)
The epidemic of obesity and changes in food intake: the Fluoride Hypothesis (2004) (97)
FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials (2016) (95)
Obesity: definition, diagnosis and disadvantages (1985) (94)
Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors (2013) (94)
Ethnic‐Specific BMI and Waist Circumference Thresholds (2011) (94)
Comparison of ventromedial and paraventricular lesions in rats that become obese. (1986) (94)
Lipogenesis in human adipose tissue: some effects of nibbling and gorging. (1972) (93)
Physical activity in individuals at risk for diabetes: Diabetes Prevention Program. (2006) (93)
Actos Now for the prevention of diabetes (ACT NOW) study (2009) (93)
Fructose: Pure, White, and Deadly? Fructose, by Any other Name, is a Health Hazard (2010) (92)
Skinfold thickness measurements in obese subjects. (1990) (92)
Effects of Weight Loss, Weight Cycling, and Weight Loss Maintenance on Diabetes Incidence and Change in Cardiometabolic Traits in the Diabetes Prevention Program (2014) (91)
Genetic obesity in rats. I. The effects of food restriction on body composition and hypothalamic function. (1973) (91)
Brown adipose tissue: thermic response increased by a single low protein, high carbohydrate meal. (1981) (90)
Fat and carbohydrate balances during adaptation to a high-fat diet (2000) (90)
Long-term calorie restriction reduces energy expenditure in aging monkeys. (1999) (90)
Peptides affect the intake of specific nutrients and the sympathetic nervous system. (1992) (90)
Intrahypothalamic injection of insulin decreases firing rate of sympathetic nerves. (1987) (89)
Transplantation of pancreatic beta-cells prevents development of hypothalamic obesity in rats. (1978) (89)
Lateral hypothalamic lesions and norepinephrine turnover in rats. (1983) (89)
Hyperinsulinemia and insulin resistance in genetically obese rats. (1972) (87)
Fructose and Risk of Cardiometabolic Disease (2012) (87)
Energy expenditure in lean and obese prepubertal children. (1995) (86)
Weight gain of rats fed medium-chain triglycerides is less than rats fed long-chain triglycerides. (1980) (85)
Obesity--a disease of nutrient or energy balance? (2009) (85)
Differential Effects of Baseline Macronutrient Preferences on Macronutrient Selection After Galanin, NPY, and an Overnight Fast (1997) (85)
Fructose: should we worry? (2008) (85)
Intestinal bypass surgery for obesity decreases food intake and taste preferences. (1976) (84)
Diurnal changes in sympathetic activity. Relation to food intake and to insulin injected into the ventromedial or suprachiasmatic nucleus. (1988) (84)
Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity. Effects of dietary composition and adipose cell size. (1974) (84)
Update on obesity pharmacotherapy (2014) (84)
Neuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span. (2001) (84)
Comparison of metabolic alterations in hypothalamic and high fat diet-induced obesity. (1977) (83)
Energy intake and energy expenditure: a controlled study comparing dietitians and non-dietitians. (2002) (83)
Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial. (2012) (83)
Effects of corticotropin releasing factor on genetically obese (fatty) rats (1989) (82)
Prevention of Diabetes With Pioglitazone in ACT NOW (2013) (82)
Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. (2005) (82)
Concurrent physical activity increases fat oxidation during the shift to a high-fat diet. (2000) (82)
Dietary intake in the diabetes prevention program cohort: baseline and 1-year post randomization. (2004) (82)
The hypothalamic-pituitary axis in genetically obese (ob/ob) mice: response to luteinizing hormone-releasing hormone. (1978) (81)
Effects of adrenalectomy on body weight and the size and number of fat cells in the Zucker (fatty) rat. (1978) (80)
Adrenalectomy and food restriction in the genetically obese (ob/ob) mouse. (1984) (80)
Patterns of Weight Change Associated With Long‐Term Weight Change and Cardiovascular Disease Risk Factors in the Look AHEAD Study (2012) (80)
Potent and Selective Agonism of the Melanocortin Receptor 4 With MK‐0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy (2009) (79)
Energy expenditure in preadolescent African American and white boys and girls: the Baton Rouge Children's Study. (2002) (79)
Enterostatin suppresses food intake following injection into the third ventricle of rats (1991) (79)
Metabolic factors in the control of energy stores. (1975) (79)
Reciprocal relation between the sympathetic nervous system and food intake (1991) (79)
Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. (1995) (79)
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. (2011) (78)
RELATION OF THYROID HORMONES TO BODY-WEIGHT (1976) (78)
Intestinal adaptation after jejunoileal bypass in man. (1977) (77)
Intestinal bypass operation as a treatment for obesity. (1976) (77)
The acute effects of food intake on energy expenditure during cycle ergometry. (1974) (77)
Lower Total Adipocyte Number but No Evidence for Small Adipocyte Depletion in Patients With Type 2 Diabetes (2009) (77)
Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. (1998) (77)
Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. (1999) (76)
Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice. (1987) (75)
Preoptic area injection of corticotropin-releasing hormone stimulates sympathetic activity. (1990) (75)
Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue (1996) (74)
Plasma triglycerides in genetically obese rats. (1969) (74)
Effects of castration, estrogen replacement and estrus cycle on monoamine metabolism in the nucleus accumbens, measured by microdialysis (1993) (74)
Hyperphagia: Current concepts and future directions proceedings of the 2nd international conference on hyperphagia (2014) (73)
Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self-administration in "anxious" rats. (2006) (72)
Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine. (1999) (72)
Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial. (2012) (71)
Activation of hypothalamic serotonin receptors reduced intake of dietary fat and protein but not carbohydrate. (1999) (71)
The effect of intrahypothalamic injections of glucose on sympathetic efferent firing rate (1987) (71)
Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice. (1983) (70)
Adrenalectomy increases norepinephrine turnover in brown adipose tissue of obese (ob/ob) mice. (1984) (70)
Autonomic activity assessed by heart rate spectral analysis varies with fat distribution in obese women. (1996) (70)
Obesity related morbidity and mortality. (2005) (69)
Low-fat diets are preferred. (2002) (69)
Effects of MSH on food intake, body weight and coat color of the yellow obese mouse. (1989) (69)
Synthesis of fatty acids and cholesterol by liver, adipose tissue and intestinal mucosa from obese and control patients (1979) (69)
Medical treatment of obesity: the past, the present and the future. (2014) (69)
Reproductive function in the genetically obese "fatty" rat. (1973) (68)
Structural requirements for the biological activity of enterostatin (1994) (68)
Autonomic and endocrine factors in the regulation of food intake (1985) (68)
Effect of urea on urine concentration in the rat. (1961) (68)
Obesity and the Metabolic Syndrome: implications for dietetics practitioners. (2004) (68)
Mifepristone (RU 486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity. (1992) (67)
Molecular and genetic aspects of obesity (1996) (67)
First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes (2008) (67)
Prediction equations for resting energy expenditure in overweight and normal-weight black and white children. (2004) (67)
Flexible vs. Rigid Dieting Strategies: Relationship with Adverse Behavioral Outcomes (1999) (66)
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study (2010) (66)
Low-carbohydrate diets and realities of weight loss. (2003) (66)
The effects of a high fat diet on leptin mRNA, serum leptin and the response to leptin are not altered in a rat strain susceptible to high fat diet-induced obesity. (1998) (66)
Effects of neuropeptide Y on norepinephrine and serotonin metabolism in rat hypothalamus in vivo (1989) (65)
Differential effects of enterostatin, galanin and opioids on high-fat diet consumption (1995) (65)
Obesity: a serious symptom. (1972) (65)
Fat and carbohydrate balances during adaptation to a high-fat. (2000) (65)
Increased expression of mu opioid receptors in animals susceptible to diet-induced obesity (2006) (65)
Fluoxetine treatment of the obese diabetic. (1992) (64)
An autonomic hypothesis for hypothalamic obesity. (1979) (64)
Altered body composition in type 2 diabetes mellitus (2008) (64)
Genetic Determinant for Amino Acid Metabolites and Changes in Body Weight and Insulin Resistance in Response to Weight-Loss Diets: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) Trial (2013) (64)
Measurement of subcutaneous fat cells from obese patients. (1970) (64)
Fat distribution and body weight. (1993) (64)
Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: Results from the look AHEAD randomized trial (2012) (63)
Differential expression of leptin receptor in high- and low-fat-fed Osborne-Mendel and S5B/Pl rats. (2000) (63)
The Nutrient Balance Hypothesis: Peptides, Sympathetic Activity, and Food Intake a (1993) (63)
Central administration of the RFamide peptides, QRFP-26 and QRFP-43, increases high fat food intake in rats (2008) (63)
Long-term impact of behavioral weight loss intervention on cognitive function. (2014) (63)
Effects of dietary preference and galanin administration in the paraventricular or amygdaloid nucleus on diet self-selection (1996) (63)
Pharmaceutical cost savings of treating obesity with weight loss medications. (1999) (63)
Effect of norepinephrine, serotonin and tryptophan on the firing rate of sympathetic nerves (1989) (62)
Energy expenditure in African American and white boys and girls in a 2-y follow-up of the Baton Rouge Children's Study. (2004) (62)
FTO genotype, dietary protein, and change in appetite: the Preventing Overweight Using Novel Dietary Strategies trial. (2014) (62)
Plasma zinc and copper in obesity and after intestinal bypass. (1978) (62)
Role of thyroid hormones in lipolysis. (1966) (62)
β-Casomorphins Stimulate and Enterostatin Inhibits the Intake of Dietary Fat in Rats (1998) (61)
Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials. (2016) (61)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY. (2015) (61)
Etiology and pathogenesis of obesity. (1999) (61)
Obesity: basic considerations and clinical approaches. (1989) (61)
Effect of Enterostatin and Kappa-Opioids on Macronutrient Selection and Consumption (1997) (60)
Leptin and leptinomania (1996) (60)
Adrenalectomy reverses insulin resistance in muscle from obese (ob/ob) mice. (1984) (60)
The missing link - lose weight, live longer. (2007) (59)
Effect of diet and triiodothyronine on the activity of sn-glycerol-3-phosphate dehydrogenase and on the metabolism of glucose and pyruvate by adipose tissue of obese patients. (1969) (59)
Effect of transplantation of pancreas on development of hypothalamic obesity (1977) (59)
Obesity increases risk for diabetes. (1992) (58)
Barriers to the treatment of obesity. (1991) (58)
Freezing point depression of rat kidney slices during water diuresis and antidiuresis (1960) (58)
Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories (2018) (58)
Calorigenic effect of human growth hormone in obesity. (1969) (58)
Effects of food restriction and adrenalectomy in rats with VMH or PVH lesions (1989) (58)
Effect of starvation and food intake on sympathetic activity. (1988) (57)
Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists (1992) (57)
Intensive Weight Loss Intervention in Older Individuals: Results from the Action for Health in Diabetes Type 2 Diabetes Mellitus Trial (2013) (57)
Sympathetic activity following paraventricular or ventromedial hypothalamic lesions in rats (1988) (56)
A paradigm of experimentally induced mild hyperthyroidism: effects on nitrogen balance, body composition, and energy expenditure in healthy young men. (1997) (56)
Risks of obesity. (2003) (56)
Hypothalamic obesity : The autonomic hypothesis and the lateral hypothalamus. (1981) (56)
Effect of triiodothyronine on some metabolic responses of obese patients. (1973) (56)
Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk (2013) (56)
Hypothalamic and genetic obesity: an appraisal of the autonomic hypothesis and the endocrine hypothesis. (1984) (56)
Obesity--a state of reduced sympathetic activity and normal or high adrenal activity (the autonomic and adrenal hypothesis revisited). (1990) (56)
Adherence is a multi-dimensional construct in the POUNDS LOST trial (2010) (55)
Catecholamine turnover in rats with ventromedial hypothalamic lesions. (1984) (55)
Sympathetic activity and food intake of rats with ventromedial hypothalamic lesions. (1988) (55)
Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions. (1986) (55)
Genetics of human obesity: research directions (1997) (55)
Corrective responses in human food intake identified from an analysis of 7-d food-intake records. (2008) (55)
Comparison of Osborne-Mendel and S5B/PL strains of rat: central effects of galanin, NPY, beta-casomorphin and CRH on intake of high-fat and low-fat diets. (1996) (55)
Effect of diet composition and weight loss on resting energy expenditure in the POUNDS LOST study (2012) (55)
Regulation of Body Weight. Biological and Behavioral Mechanisms. (1996) (54)
Hepatic sodium-potassium-dependent ATPase in obesity. (1981) (54)
Is it Time to Change the Way We Report and Discuss Weight Loss? (2009) (54)
Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment (2017) (54)
The myth of diet in the management of obesity. (1970) (54)
Relation of adipose tissue to metabolic flexibility. (2009) (54)
GABA-related feeding control in genetically obese rats (1991) (53)
Topical fat reduction. (1995) (53)
Alcohol consumption and diabetes risk in the Diabetes Prevention Program. (2009) (52)
American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes. (2010) (52)
APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial. (2012) (52)
The DASH diet for high blood pressure: from clinical trial to dinner table. (2004) (51)
Nicotine increases thermogenesis in brown adipose tissue in rats (1988) (51)
Studies on lipolysis in human adipose cells. (1967) (50)
Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST study (2010) (50)
A beta-3 adrenergic agonist (BRL-37,344) decreases food intake. (1998) (50)
Macronutrient Diet Intake of the Lethal Yellow Agouti (Ay/a) Mouse (1999) (50)
Effects of a high-fat diet and strain on hypothalamic gene expression in rats. (2002) (50)
Cholecystokinin and satiety. (1977) (50)
Obesity: the disease. (2006) (50)
Underreporting of energy intake in biracial children is verified by doubly labeled water. (1996) (50)
A 9-mo randomized clinical trial comparing fat-substituted and fat-reduced diets in healthy obese men: the Ole Study. (2002) (50)
Overweight and obesity: the pathogenesis of cardiometabolic risk. (2009) (49)
Hypothalamic obesity (1981) (49)
Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study (2017) (49)
Chronic effects of intracerebral ventricular enterostatin in Osborne-Mendel rats fed a high-fat diet (1993) (49)
Changes in Gut Microbiota–Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial (2018) (48)
Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial (2016) (48)
Effects of triiodothyronine, growth hormone and anabolic steroids on nitrogen excretion and oxygen consumption of obese patients. (1971) (47)
Effect of protein overfeeding on energy expenditure measured in a metabolic chamber. (2015) (47)
A survey of the opinions of obesity experts on the causes and treatment of obesity. (1992) (47)
Integration of energy intake and expenditure in animals and man: the autonomic and adrenal hypothesis. (1984) (47)
Opiate receptors, food intake and obesity (1982) (47)
Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity (2005) (47)
Studies on hypothermia and thyroid function in the obese (ob/ob) mouse. (1976) (47)
Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease? (1997) (47)
Regulation of energy balanc: studies on gnetic, hypothalamic and dietary obesity (1982) (46)
Effect of NPY5R Antagonist MK‐0557 on Weight Regain after Very‐low‐calorie Diet‐induced Weight Loss (2007) (46)
The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial (2017) (46)
Thyrotropin secretion in genetically obese rats. (1972) (46)
Effects of cholecystokinin on sympathetic activity to interscapular brown adipose tissue (1992) (46)
Effects of pyruvate and lactate on food intake in rat strains sensitive and resistant to dietary obesity (1996) (46)
Trunk Versus Extremity Adiposity and Cardiometabolic Risk Factors in White and African American Adults (2011) (46)
Drug Treatment of Obesity (2001) (46)
Peripheral administration of human corticotropin-releasing hormone: a novel method to increase energy expenditure and fat oxidation in man. (2001) (45)
Differential Satiating Effects of Fats in the Small Intestine of Obesity-Resistant and Obesity-Prone Rats (1999) (45)
Vagal-central nervous system interactions modulate the feeding response to peripheral enterostatin. (1994) (45)
Percent body fat measured by BIA and DEXA in obese, African-American adolescent girls (2005) (45)
Predicting obesity in adults from childhood and adolescent weight. (2002) (45)
Evaluation of drugs for treating obesity. (1995) (44)
Evaluation of obesity (2003) (44)
Dietary fat affects obesity rate. (1999) (44)
Procolipase mRNA: tissue localization and effects of diet and adrenalectomy. (1993) (44)
Prediction of energy expenditure in a whole body indirect calorimeter at both low and high levels of physical activity (2001) (44)
Variants in glucose- and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: the POUNDS LOST Trial. (2014) (44)
Olfactory bulbectomy increases food intake and hypothalamic neuropeptide Y in obesity-prone but not obesity-resistant rats (2007) (44)
Effect of Fasting (2017) (44)
Lateral hypothalamic lesions and activity of the sympathetic nervous system. (1987) (44)
Sex Differences in the Effects of Weight Loss Diets on Bone Mineral Density and Body Composition: POUNDS LOST Trial. (2015) (43)
Chronic d-Fenfluramine Treatment Reduces Fat Intake Independent of Macronutrient Preference (1998) (43)
Macronutrient Intake–Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial (2016) (43)
Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease[S] (2014) (43)
Chamber for indirect calorimetry with accurate measurement and time discrimination of metabolic plateaus of over 20 min (2003) (43)
Evaluation of the obese patient. 1. An algorithm. (1976) (43)
Surgical treatment of obesity: a review of our experience and an analysis of published reports. (1977) (43)
A Long-Term Intensive Lifestyle Intervention and Physical Function: the Look AHEAD Movement and Memory Study (2014) (42)
Dynamic and static phases of obesity following lesions in PVN and VMH. (1987) (42)
Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS) (2019) (42)
The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. (2009) (42)
Americans on diet: results from the 1994-1996 Continuing Survey of Food Intakes by Individuals. (2002) (42)
The peptide enterostatin may produce early satiety (1993) (42)
Pharmacologic Treatment Options for Obesity: What Is Old Is New Again (2013) (42)
Treatment of hypothalamic obesity with caffeine and ephedrine. (2008) (42)
Describing patterns of weight changes using principal components analysis: results from the Action for Health in Diabetes (Look AHEAD) research group. (2009) (42)
Factors Affecting the Decline in Incidence of Diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS) (2014) (42)
Effect of adrenalectomy and high-fat diet on the fatty Zucker rat. (1992) (42)
Diabetes Prevention Program (DPP) (2020) (41)
Drug treatment of obesity. (2001) (41)
Genetic, hypothalamic and endocrine features of clinical and experimental obesity. (1992) (41)
American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action. (2014) (41)
Body composition and childhood obesity. (1996) (41)
Use of a Computerized Tracking System to Monitor and Provide Feedback on Dietary Goals for Calorie-Restricted Diets: The POUNDS LOST Study (2012) (41)
Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat (2000) (40)
Relationships between oxygen consumption and body composition of obese patients. (1970) (40)
Testosterone administration preserves protein balance but not muscle strength during 28 days of bed rest. (1999) (40)
Obesity: Towards a molecular approach (1990) (40)
Effects of Adrenalectomy on Thyroid Function and Insulin Levels in Obese (ob/ob) Mice (1978) (40)
Effects of intraventricular infusion of corticotropin-releasing factor on VMH-lesioned obese rats. (1989) (40)
Substrate oxidation and energy expenditure in athletes and nonathletes consuming isoenergetic high- and low-fat diets. (1998) (40)
Autonomic and endocrine factors in the regulation of energy balance. (1986) (40)
Energy expenditure and substrate oxidation predict changes in body fat in children. (2006) (40)
Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention. (2015) (40)
Effects of 2-deoxy-D-glucose on sympathetic nerve activity to interscapular brown adipose tissue. (1989) (40)
Effect of Diet Composition on Energy Expenditure during Weight Loss: The POUNDS LOST Study (2011) (40)
A randomized double-blind clinical trial of fluoxetine in obese diabetics. (1992) (39)
Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes. (2010) (39)
1989 McCollum Award lecture. Genetic and hypothalamic mechanisms for obesity--finding the needle in the haystack. (1989) (39)
Neuropeptide Y administration into the amygdala alters high fat food intake (2006) (38)
Estimation of energy requirements in a controlled feeding trial. (2003) (38)
Changes in Body Composition over Eight Years in a Randomized Trial of a Lifestyle Intervention: The Look AHEAD Study (2014) (38)
Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial. (2016) (38)
Evidence‐based weight loss interventions: Individualized treatment options to maximize patient outcomes (2020) (38)
GDF 15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans (2019) (38)
Metabolism of α-Glycerol Phosphate in Human Adipose Tissue in Obesity1 (1967) (38)
Effect of intrahypothalamic hydroxybutyrate on sympathetic firing rate. (1988) (37)
Opioid receptor subtype control of galanin-induced feeding (1996) (37)
Intestinal bypass for obesity a summary and perspective. (1977) (37)
Some respiratory and metabolic effects of exercise in moderately obese men. (1977) (37)
Predicting successful long-term weight loss from short-term weight-loss outcomes: new insights from a dynamic energy balance model (the POUNDS Lost study). (2015) (37)
Meal-induced brown fat thermogenesis and thyroid hormone metabolism in rats. (1985) (37)
Constitutive activation of STAT-3 and downregulation of SOCS-3 expression induced by adrenalectomy. (2001) (36)
Effects of acute transitory urinary obstruction in the dog. (1960) (36)
Thyroid function of genetically obese rats. (1971) (36)
Effects of glucose, 2-deoxyglucose, phlorizin, and insulin on food intake of lean and fatty rats. (1990) (36)
Association of dietary restraint and disinhibition with eating behavior, body mass, and hunger (1998) (36)
First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes (2009) (36)
The energetics of obesity. (1983) (36)
Combination Drugs for Treating Obesity (2010) (36)
Food intake, sympathetic activity, and adrenal steroids (1993) (36)
PCSK7 Genotype Modifies Effect of a Weight-Loss Diet on 2-Year Changes of Insulin Resistance: The POUNDS LOST Trial (2014) (36)
Effects of epinephrine on glucose transport and metabolism in adipose tissue of normal and hypothyroid rats. (1968) (36)
Food intake and body weight regulation. (1996) (36)
Why do we need drugs to treat the patient with obesity? (2013) (35)
Nutrient intake is modulated by peripheral peptide administration. (1995) (35)
Sodium potassium dependent ATPase in hypophysectomized rats: response to growth hormone, triiodothyronine, and cortisone. (1982) (35)
Diet type and changes in food cravings following weight loss: Findings from the POUNDS LOST Trial (2012) (35)
Human chorionic gonadotropin (HCG) in the treatment of obesity: a critical assessment of the Simeons method. (1977) (35)
The impact of lifestyle intervention on sedentary time in individuals at high risk of diabetes (2015) (35)
The Look AHEAD Trial: Bone Loss at 4-Year Follow-up in Type 2 Diabetes (2014) (34)
Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial. (2015) (34)
Lateral hypothalamus and sympathetic firing rate. (1988) (34)
Body composition of African American and white children: a 2-year follow-up of the BAROC study. (2001) (34)
Progress in understanding the genetics of obesity. (1997) (34)
Evidence for a circulating ergostatic factor: studies on parabiotic rats. (1980) (34)
The Role of Macronutrient Content in the Diet for Weight Management. (2016) (34)
CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials1 (2015) (34)
Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome (2009) (34)
Effect of Dietary Composition of Weight Loss Diets on High Sensitivity C-Reactive Protein: The Randomized POUNDS LOST Trial (2012) (34)
Activity of (Na+ + K+)-ATPase in the liver of animals with experimental obesity. (1978) (34)
Eating patterns of massively obese individuals. (1978) (34)
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW. (2016) (34)
Effect of weight reduction, triiodothyronine, and diethylstilbestrol on growth hormone in obesity. (1969) (34)
Intragastric β-casomorphin1–7 attenuates the suppression of fat intake by enterostatin☆ (2000) (33)
Effects of repeated weight loss and regain on body composition in obese rats. (1988) (33)
Fiber Intake Predicts Weight Loss and Dietary Adherence in Adults Consuming Calorie-Restricted Diets: The POUNDS Lost (Preventing Overweight Using Novel Dietary Strategies) Study. (2019) (33)
Obesity-inducing hypothalamic knife cuts: effects on lipolysis and blood insulin levels. (1982) (33)
Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program (2012) (33)
Day-to-day variation in food intake and energy expenditure in healthy women: the Dietitian II Study. (2013) (33)
Brain 3-hydroxybutyrate, glutamate, and GABA in a rat model of dietary obesity (1989) (33)
Secondary amenorrhea in obesity: etiologic role of weight-related androgen excess. (1978) (33)
Colonic pseudo-obstruction: a new complication of jejunoileal bypass. (1975) (32)
Effects of insulin on hypothalamic monoamine metabolism (1990) (32)
Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system. (2011) (32)
A Guide to Obesity and the Metabolic Syndrome: Origins and Treatment (2011) (32)
Hyperinsulinemia in rats with hypothalamic obesity: effects of autonomic drugs and glucose. (1983) (32)
Differential modulation of Toll-like receptors by fatty acids Published, JLR Papers in Press, December 1, 2002. DOI 10.1194/jlr.M200361-JLR200 (2003) (32)
Lateral hypothalamic lesions and fenfluramine increase thermogenesis in brown adipose tissue (1986) (32)
The Effects on Feeding of Galanin and M40 When Injected Into the Nucleus of the Solitary Tract, the Lateral Parabrachial Nucleus, and the Third Ventricle (1999) (32)
Diet, lighting, and food intake affect norepinephrine turnover in dietary obesity. (1987) (32)
Treatment of obesity: cost-benefit assessment of behavioral therapy, placebo, and two anorectic drugs. (1978) (31)
Spontaneous and experimental human obesity: effects of diet and adipose cell size on lipolysis and lipogenesis. (1977) (31)
Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial (2013) (31)
Intensive Weight Loss Intervention and Cancer Risk in Adults with Type 2 Diabetes: Analysis of the Look AHEAD Randomized Clinical Trial (2020) (31)
Prevention of Diabetes Through Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to Practice (2014) (31)
Physiological relationships of uncoupling protein-2 gene expression in human adipose tissue in vivo. (2000) (31)
Preferential Fat Intake Increases Adiposity but not Body Weight in Sprague-Dawley Rats (1998) (31)
Predictors of successful weight loss in an outpatient obesity clinic. (1977) (31)
Genetic obesity in rats. II. The effect of food restriction on the metabolism of adipose tissue. (1973) (31)
Treatment of the Obese Patient in Primary Care: Targeting and Meeting Goals and Expectations (2013) (31)
Effect of a high-fat diet on firing rate of sympathetic nerves innervating brown adipose tissue in anesthetized rats (1989) (30)
High Fat Diet Differentially Regulates the Expression of Olfactory Receptors in the Duodenum of Obesity-Prone and Obesity-Resistant Rats (2012) (30)
Ovarian hormones influence brown adipose tissue (1983) (30)
Role of the autonomic nervous system in the development of ventromedial hypothalamic obesity (1980) (30)
The biology of human overfeeding: A systematic review. (2020) (30)
Improving long‐term weight loss maintenance: Can we do it? (2015) (30)
Obesity and Lipoprotein Metabolism (2003) (30)
Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. (2010) (30)
Clinical evaluation of the overweight patient (2000) (30)
STUDIES ON THE EARLY EFFECTS OF THYROID HORMONES. (1965) (30)
Treatment of obesity: comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double-blind trial. (1977) (30)
Regulation of beta 3-adrenergic receptor mRNA by sympathetic nerves and glucocorticoids in BAT of Zucker obese rats. (1995) (30)
Nutrient balance and obesity: an approach to control of food intake in humans. (1989) (30)
Mycotoxins, cancer, and health. (1991) (29)
Drug Insight: appetite suppressants (2005) (29)
Good Calories, Bad Calories by Gary Taubes; New York: AA Knopf (2008) (29)
Changes in Visceral Adiposity, Subcutaneous Adiposity, and Sex Hormones in the Diabetes Prevention Program (2017) (29)
Determinants of sedentary 24-h energy expenditure: equations for energy prescription and adjustment in a respiratory chamber. (2014) (29)
Glucagon injected in the lateral hypothalamus stimulates sympathetic activity and suppresses monoamine metabolism (1993) (29)
Peripheral 3-hydroxybutyrate and food intake in a model of dietary-fat induced obesity: Effect of vagotomy (1995) (29)
Hypothalamic monoamines measured by microdialysis in rats treated with 2-deoxy-glucose or d-fenfluramine (1989) (29)
Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity. (2015) (29)
Are Non‐prescription Medications Needed for Weight Control? (2008) (29)
Muscle Protein Turnover in the Perfused Hindquarters of Lean and Genetically Obese-Diabetic (db/db) Mice (1984) (29)
Genetic susceptibility to diabetes and long-term improvement of insulin resistance and β cell function during weight loss: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. (2016) (28)
Depression as a Predictor of Weight Regain Among Successful Weight Losers in the Diabetes Prevention Program (2013) (28)
Sympathetic activity following paraventricular injections of glucose and insulin (1988) (28)
The inheritance of corpulence. (1994) (28)
Experience with jejunoileal bypass for obesity. (1976) (28)
Effect of fenfluramine on GDP-binding to brown adipose tissue mitochondria (1985) (28)
Obesity-resistant S5B rats showed greater cocaine conditioned place preference than the obesity-prone OM rats (2010) (27)
Handbook of Obesity: Epidemology, Etiology, and Physiopathology (2014) (27)
Effect of fenfluramine on sympathetic firing rate (1988) (27)
Feeding response to mercaptoacetate in Osborne-Mendel and S5B/PL rats. (1997) (27)
Macronutrient selection following 2-deoxy-d-glucose and mercaptoacetate administration in rats (1998) (27)
Drug treatment of obesity. (1999) (27)
Medical therapy for obesity. (2010) (27)
d-Fenfluramine in a rat model of dietary fat-induced obesity (1993) (27)
Anthropometric Markers of Obesity and Mortality in White and African American Adults: The Pennington Center Longitudinal Study (2012) (27)
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures. (2020) (27)
Obesity. Part II--Treatment. (1988) (27)
Starch Digestion–Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets: The POUNDS Lost Trial (2017) (27)
Brain uptake of ketones in rats with differing susceptibility to dietary obesity. (1987) (27)
Don't throw the baby out with the bath water. (2004) (27)
Obesity in Osborne-Mendel and S 5B/Pl rats: effects of sucrose solutions, castration, and treatment with estradiol or insulin. (1982) (27)
Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention Program (2017) (27)
Medications for obesity: mechanisms and applications. (2009) (26)
Effects of epinephrine, corticotropin, and thyrotropin on lipolysis and glucose oxidation in rat adipose tissue. (1967) (26)
Drug treatment of obesity: don't throw the baby out with the bath water. (1998) (26)
Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study (2020) (26)
Physical activity and body weight regulation. (1996) (26)
Treatment for obesity: a nutrient balance/nutrient partition approach. (2009) (26)
Therapeutic controversy: Obesity--a modern-day epidemic. (1999) (26)
IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention (2013) (26)
An objective estimate of energy intake during weight gain using the intake-balance method. (2014) (25)
Food deprivation increases the mRNA expression of micro-opioid receptors in the ventral medial hypothalamus and arcuate nucleus. (2008) (25)
Effect of beta-endorphin on sympathetic nerve activity to interscapular brown adipose tissue. (1993) (25)
Ventromedial hypothalamic lesions attenuate responses of sympathetic nerves to carotid arterial infusions of glucose and insulin. (1990) (25)
Pretreatment Fasting Glucose and Insulin as Determinants of Weight Loss on Diets Varying in Macronutrients and Dietary Fibers—The POUNDS LOST Study (2019) (25)
Coherent, preventive and management strategies for obesity. (2007) (25)
CD36 mRNA in the Gastrointestinal Tract Is Differentially Regulated by Dietary Fat Intake in Obesity-Prone and Obesity-Resistant Rats (2013) (25)
Effect of Estradiol on Uterine Weight, Thyroid Function, Food Intake, and Pituitary Weight of Genetically Obese (Fatty-Zucker) and Lean Rats (1976) (25)
What is the ideal body weight (1998) (25)
Socioeconomic Status and Health Disparity in the United States (2007) (25)
Effects of weight gain induced by controlled overfeeding on physical activity. (2014) (25)
Corticosterone inhibition of the intracerebroventricular effect of 2-deoxy-D-glucose on brown adipose tissue thermogenesis (1987) (25)
Effect of a β-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity (2004) (24)
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. (2015) (24)
Studies on the sensitivity to catecholamines after thyroidectomy. (1966) (24)
ETIOLOGY AND NATURAL HISTORY OF OBESITY (2002) (24)
Regulation of ghrelin gene expression in stomach and feeding response to a ghrelin analogue in two strains of rats (2004) (24)
Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial. (2015) (24)
How do we get fat? An epidemiologic and metabolic approach. (2004) (24)
Treatment of obesity by acupuncture. (1976) (24)
Inhibition of glucose oxidation in adipose tissue by dibutyryladenosine-3',5'-phosphate. (1967) (24)
Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial (2019) (24)
Preference for a high fat diet, but not hyperphagia following activation of mu opioid receptors is blocked in AgRP knockout mice (2010) (23)
Alterations in blood glucose, insulin, and free fatty acids following lateral hypothalamic lesions or parasagittal knife cuts (1980) (23)
Medications for weight reduction. (2011) (23)
The ischymetric control of feeding. Commentaries. Author's reply (1990) (23)
Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects. (1986) (23)
Enterostatin suppresses food intake in rats after near-celiac and intracarotid arterial injection. (2000) (23)
Whole body insulin sensitivity in Osborne-Mendel and S 5B/Pl rats eating a low- or high-fat diet. (1992) (23)
Static theories in a dynamic world: a glucodynamic theory of food intake. (1996) (23)
Insulin, glucose, growth hormone, and free fatty acids. Determinations in patients with cystic fibrosis. (1971) (23)
Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: the Ole' Study (2003) (23)
Effect of mazindol, d-amphetamine and diethylpropion on purine nucleotide binding to brown adipose tissue (1986) (22)
Lipolysis in human adipose tissue: comparison of human pituitary hormones with other lipolytic agents. (1972) (22)
Adrenal sympathetic nerve activity in response to hypothalamic injections of 2-deoxy-D-glucose. (1991) (22)
Management of Obesity by Severe Caloric Restriction (1985) (22)
Testosterone and depressive symptoms among men in the Diabetes Prevention Program (2016) (22)
Effect of enterostatin on the feeding responses to galanin and NPY. (1993) (22)
Diet, weight loss, and cardiovascular disease prevention (2003) (22)
Current Status of Intestinal Bypass Surgery in the Treatment of Obesity (1977) (22)
Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions (2018) (22)
Lipogenesis from glucose and pyruvate in fat cells from genetically obese rats. (1968) (22)
Sensitivity to the satiating effects of Exendin 4 is decreased in obesity-prone Osborne-Mendel rats compared to obesity-resistant S5B/Pl rats (2010) (22)
Guidelines for surgery for morbid obesity (1985) (22)
Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets. (2016) (22)
Catecholamine turnover in S 5B/P1 and Osborne-Mendel rats: response to a high-fat diet. (1984) (22)
Genetic variation of fasting glucose and changes in glycemia in response to 2-year weight-loss diet intervention: the POUNDS Lost trial (2016) (22)
Nutrition, aging and reproduction in rhesus monkeys. (1998) (22)
Medical therapy for obesity--current status and future hopes. (2007) (22)
Syndromes of hypothalamic obesity in man. (1984) (22)
Adrenalectomy of the obese Zucker rat: effects on the feeding response to enterostatin and specific mRNA levels. (1993) (21)
Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and Behavioral Factors Affecting Changes in Body Weight, Body Composition, and Cardiometabolic Risk (2019) (21)
Effects of thyroid hormone and adrenalectomy on [Na+ + K+]ATPase in the ob/ob mouse. (1981) (21)
Exercise energetics in normal man following acute weight gain. (1973) (21)
An Atlas of Obesity and Weight Control (2002) (21)
Compositional and metabolic changes in brown adipose tissue following a single test meal. (1983) (21)
Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice. (1986) (21)
Modulation by corticotropin-releasing factor of monoamine metabolism in the lateral hypothalamus (1989) (20)
Differential Response to Kappa-Opioidergic Agents in Dietary Fat Selection Between Osborne-Mendel and S5B/Pl Rats (1998) (20)
Effects of diet and time of the day on serum and CSF leptin levels in Osborne-Mendel and S5B/Pl rats. (2004) (20)
Guanosine diphosphate binding to brown adipose tissue mitochondria is increased after single meal. (1985) (20)
STUDIES ON THE INTERACTIONS OF THYROID HORMONE AND CATECHOLAMINES. (1964) (20)
Life insurance and overweight. (1995) (20)
Body Image Changes Associated With Participation in an Intensive Lifestyle Weight Loss Intervention (2011) (20)
Mobilization of fatty acids in genetically obese rats. (1970) (20)
Perception of Sweetness Intensity Determines Women's Hedonic and other Perceptual Responsiveness to Chocolate Food (1998) (20)
High-fat/low-carbohydrate diets regulate glucose metabolism via a long-term transcriptional loop. (2006) (20)
Adrenergic modulation of glucagon and insulin secretion in obese and lean humans. (1981) (20)
In defense of a body mass index of 25 as the cut-off point for defining overweight. (1998) (20)
Pharmacological approaches to treating the obese patient. (1976) (19)
A circadian rhythm-related MTNR1B genetic variant modulates the effect of weight-loss diets on changes in adiposity and body composition: the POUNDS Lost trial (2019) (19)
Markers of dietary protein intake are associated with successful weight loss in the POUNDS Lost trial (2017) (19)
Parental longevity and diabetes risk in the Diabetes Prevention Program. (2011) (19)
Effects of experimentally induced mild hyperthyroidism on growth hormone and insulin secretion and sex steroid levels in healthy young men. (1997) (19)
Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial (2015) (19)
Relationship between food intake and metabolic rate in rats treated with beta-adrenoceptor agonists. (1994) (19)
Drug treatment of obesity. (1992) (19)
Dietary Protein Modifies the Effect of the MC4R Genotype on 2-Year Changes in Appetite and Food Craving: The POUNDS Lost Trial. (2017) (19)
Drug treatment of obesity. (2005) (19)
Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program. (2016) (19)
Rhythmic changes in renal function in the rat. (1965) (19)
Effect on Body Weight of Replacing Dietary Fat with Olestra for Two or Ten Weeks in Healthy Men and Women (2002) (19)
Cholecystokinin, bombesin and neurotensin in brain tissue from obese animals. (1984) (19)
Brown fat thermogenesis in a rat model of dietary obesity. (1987) (19)
Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats (2011) (19)
Effect of an acute reduction in carbohydrate intake on subsequent food intake in healthy men. (1997) (19)
Effects of feeding behavior of rats of a cryptic peptide from the C-terminal end on prepro-growth hormone-releasing factor. (1987) (18)
Hormonal Responses to a Fast-Food Meal Compared with Nutritionally Comparable Meals of Different Composition (2007) (18)
Suppression of appetite by bile acids. (1968) (18)
Low-dose T3 improves the bed rest model of simulated weightlessness in men and women. (1999) (18)
The metabolic syndrome : Epidemiology, Clinical Treatment, and Underlying mechanisms (2008) (18)
A Comparison of Tyrosine against Placebo, Phentermine, Caffeine, and d-Amphetamine During Sleep Deprivation (2003) (18)
Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study. (2019) (18)
Adrenalectomy and response to corticosterone and MSH in the genetically obese yellow mouse. (1989) (18)
Short-term overeating results in incomplete energy intake compensation regardless of energy density or macronutrient composition (2013) (18)
Greater Healthful Dietary Variety Is Associated with Greater 2-Year Changes in Weight and Adiposity in the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial. (2016) (17)
Studies on the Composition of Adipose Tissue from the Genetically Obese Rats∗ (1969) (17)
Genetic Variations of Circulating Adiponectin Levels Modulate Changes in Appetite in Response to Weight-Loss Diets (2016) (17)
Clinical evaluation of the obese patient. (1999) (17)
Lateral hypothalamic injection of 2-deoxy-D-glucose suppresses sympathetic activity. (1989) (17)
Accuracy of self-reported weights. (1982) (17)
Handbook of Obesity - Volume 2 : Clinical Applications, Fourth Edition (2014) (17)
Uses and misuses of the new pharmacotherapy of obesity. (1999) (17)
Effects of acarbose on food intake, body weight and fat depots in lean and obese rats (1983) (17)
Obesity: The Disease (2006) (17)
Ventromedial hypothalamic knife-cut lesions in rats resistant to dietary obesity. (1984) (17)
The thermic effect of food is reduced in obesity. (2002) (17)
Identification, Evaluation, and Treatment of Overweight and Obesity (2012) (16)
Effect of a 3-day high-fat feeding period on carbohydrate balance and ad libitum energy intake in humans (2010) (16)
Vitamin D metabolism-related genetic variants, dietary protein intake and improvement of insulin resistance in a 2 year weight-loss trial: POUNDS Lost (2015) (16)
Postprandial thermogenesis at rest and during exercise in elderly men ingesting two levels of protein. (1987) (16)
Cholecystokinin and satiety: effect of hypothalamic obesity and gastric bubble insertion. (1992) (16)
Abdominal adiposity depots are correlates of adverse cardiometabolic risk factors in Caucasian and African-American adults (2011) (16)
Effect of a serotonin 1-A agonist on food intake of Osborne–Mendel and S5B/P1 rats (2000) (16)
Genetic, epigenetic and transcriptional variations at NFATC2IP locus with weight loss in response to diet interventions: The POUNDS Lost Trial (2017) (16)
HNF1A variant, energy‐reduced diets and insulin resistance improvement during weight loss: The POUNDS Lost trial and DIRECT (2018) (16)
Metabolic and regulatory obesity in rats and man. (1970) (16)
Effect of a high or low ambient perinatal temperature on adult obesity in Osborne-Mendel and S5B/Pl rats. (2005) (16)
Erratum: Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes (Diabetes Care (2002) 25 (1033-1041)) (2003) (16)
The age of obesity. (1977) (16)
Macronutrient-specific effect of the MTNR1B genotype on lipid levels in response to 2 year weight-loss diets[S] (2017) (16)
The Metabolic Syndrome and Obesity (2007) (16)
Nutrition and obesity: prevention and treatment. (1999) (15)
Dietary obesity: Effects of drugs on food intake in S 5B/P1 and Osborne-Mendel rats (1985) (15)
The overweight patient. (1976) (15)
Lipoprotein lipase activity in adipose tissue from obese human beings. (1981) (15)
Effects of Longitudinal Glucose Exposure on Cognitive and Physical Function: Results from the Action for Health in Diabetes Movement and Memory Study (2017) (15)
Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity (2018) (15)
Treatment and management of obesity (1974) (15)
Distribution of urea, thiourea-C14 and sucrose-C14 in dog kidney during antidiuresis (1960) (15)
Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health Toolbox: The Look AHEAD study (2017) (15)
Office Management of Obesity (2003) (15)
Regulation of feeding behavior, gastric emptying, and sympathetic nerve activity to interscapular brown adipose tissue by galanin and enterostatin: the involvement of vagal-central nervous system interactions (2002) (15)
Conditioned taste aversion produced by inhibitors of fatty acid oxidation in rats (1999) (14)
Two-year changes in circulating adiponectin, ectopic fat distribution and body composition in response to weight-loss diets: the POUNDS Lost Trial (2016) (14)
The epidemic of obesity. (2000) (14)
Effect of diet on the weight of brown adipose tissue in rodents. (1981) (14)
Extracellular hypothalamic monoamines measured by in vivo microdialysis in a rat model of dietary fat-induced obesity. (1994) (14)
A Systems Genetics Approach Identified GPD1L and its Molecular Mechanism for Obesity in Human Adipose Tissue (2017) (14)
Regulation of Water Balance in Genetically Obese Rats 1 (1971) (14)
STUDIES ON THE MECHANISMS OF INSULIN RESISTANCE IN CHILDHOOD OBESITY (1974) (14)
Nutrition Guide for Physicians and Related Healthcare Professionals (2022) (14)
Lipogenesis in adipose tissue from genetically obese rats. (1970) (14)
Metabolism of adipose tissue from normal and hypothyroid rats. (1968) (13)
Early influences on body weight regulation. (1996) (13)
To treat or not to treat: that is the question. (1997) (13)
Spatial system design and fast calibration of activity interaction-allocation models (1973) (13)
Opinions of obesity experts on the causes and treatment of obesity--a new survey. (1995) (13)
Epidemiology, risks and pathogenesis of obesity. (2005) (13)
Classification and Evaluation of the Overweight Patient (2014) (13)
Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study. (2022) (13)
Metabolic determinants of body weight regulation. (1996) (12)
Adrenalectomy and castration in the genetically obese (ob/ob) mouse. (1993) (12)
Frequency of consuming foods predicts changes in cravings for those foods during weight loss: The POUNDS Lost Study (2017) (12)
Sibutramine and blood pressure: a therapeutic dilemma (2002) (12)
Obesity and mental disorders (2006) (12)
Why Obesity? (2015) (12)
Type-specific concordance in young diabetic monozygotic twins. (1988) (12)
Daily intake of multivitamins during long-term intake of olestra in men prevents declines in serum vitamins A and E but not carotenoids. (2005) (12)
Gut-microbiome related LCT genotype and 2-year changes in body composition and fat distribution: the POUNDS Lost Trial (2017) (12)
Bombesin-induced hypothermia in rats tested at normal ambient temperatures: Contribution of the sympathetic nervous system (1995) (12)
3 – The role of high sugar foods and sugar-sweetened beverages in weight gain and obesity (2015) (12)
Effect of Meta‐chlorophenylpiperazine and Cholecystokinin on Food Intake of Osborne‐Mendel and S5B/P1 Rats (2007) (12)
Coronary risk factor statement for the American public. A statement of the nutrition committee. (1985) (12)
Metabolic links between nutrition and reproduction: signals, sensors, and pathways controlling GNRH secretion. (1998) (12)
Factors controlling food intake: a comparison of dieting and intestinal bypass. (1980) (12)
A psychiatric study of patients referred with a diagnosis of hypoglycemia. (1976) (12)
New weight guidelines for Americans. (1992) (12)
Catechol-O-methyltransferase association with hemoglobin A1c. (2016) (12)
Consistency of fat mass–fat-free mass relationship across ethnicity and sex groups (2010) (12)
Interaction of adrenalectomy and fenfluramine treatment on body weight, food intake and brown adipose tissue (1989) (11)
What's in a name? Mr. Dickens' "Pickwickian" fat boy syndrome. (1994) (11)
Experimental obesity in man. A progress report. (1972) (11)
Is dietary fat important? (2011) (11)
Effect of Three Levels of Dietary Protein on Metabolic Phenotype of Healthy Individuals With 8 Weeks of Overfeeding. (2016) (11)
Peptides in regulation of energy metabolism and body weight. (1996) (11)
Overweight and the Metabolic Syndrome (2006) (11)
Absorptive capacity of the jejunum of obese and lean subjects: effect of fasting. (1972) (11)
History of Obesity (2009) (11)
Clinical management of the obese adult. (1972) (11)
Handbook of Obesity : Clinical Applications, Third Edition (2008) (11)
Endocrine factors in the modulation of food intake (1978) (11)
Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW (2014) (10)
Nutrient balance: new insights into obesity. (1987) (10)
Medications for weight reduction. (2008) (10)
More salt, please [5] (multiple letters) (1998) (10)
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance (2016) (10)
Laurence, Moon, Bardet, and Biedl: reflections on a syndrome. (1995) (10)
Luxuskonsumption--myth or reality? (1995) (10)
Effects of food and light on norepinephrine turnover. (1988) (10)
Changes in regional body composition over 8 years in a randomized lifestyle trial: The look AHEAD study (2016) (10)
Gastrointestinal hormones and weight management (2009) (10)
Placental regulation of nutrient partitioning during pregnancy. (1998) (10)
No evidence for metabolic adaptation in thermic effect of food by dietary protein (2016) (10)
Adrenalectomy in genetically obese ob/ob and db/db mice increases the proton conductance pathway. (1989) (9)
Pyruvate and hepatic pyruvate dehydrogenase levels in rat strains sensitive and resistant to dietary obesity. (1996) (9)
Sensitivity of beta-cells to streptozotocin in lean and obese rats. (1978) (9)
Establishing energy requirements for body weight maintenance: validation of an intake-balance method (2017) (9)
High-resolution identification of human adiponectin oligomers and regulation by pioglitazone in type 2 diabetic patients. (2013) (9)
Salivary gland weight and nerve growth factor in the genetically obese (ob/ob) mouse. (1982) (9)
Commentary on classics of obesity. 4. Hypothalamic obesity. (1993) (9)
Weight homeostasis. (1991) (9)
Adipose tissue expression of adipose (WDTC1) gene is associated with lower fat mass and enhanced insulin sensitivity in humans (2013) (9)
Treatment and secondary prevention of obesity. (2000) (9)
The effects of triiodothyronine on bone metabolism in healthy ambulatory men. (2003) (9)
Gastrin secretion after weight loss by dieting and intestinal bypass surgery (1979) (9)
Effect of prandial glucose on brown fat thermogenesis in rats: possible implications for dietary obesity. (1984) (9)
Low-dose T(3) improves the bed rest model of simulated weightlessness in men and women. (1999) (9)
Reply to MF Jacobson (2004) (9)
Evaluation of the obese patient. 2. Clinical findings. (1976) (9)
From farm to fat cell: why aren't we all fat? (2015) (9)
Overfeeding of Polyunsaturated Versus Saturated Fatty Acids Reduces Ectopic Fat (2014) (9)
Obesity in America. An overview of the Second Fogarty International Center Conference on Obesity. (1979) (9)
Reversal of Small, Dense LDL Subclass Phenotype by Weight Loss Is Associated With Impaired Fat Oxidation (2011) (9)
Amino acids, protein, and body weight. (1997) (8)
Is new hope on the horizon for obesity? (2008) (8)
The metabolic syndrome of human obesity. (1996) (8)
Intragastric beta-casomorphin(1-7) attenuates the suppression of fat intake by enterostatin. (2000) (8)
Pharmacologic Treatment of Obesity: Symposium Overview (1995) (8)
The detrimental effect of simmondsin on food intake and body weight of rats (2000) (8)
Plasma Amino Acids During 8 Weeks of Overfeeding: Relation to Diet Body Composition and Fat Cell Size in the PROOF Study (2018) (8)
Can we reduce snack food intake? (2009) (8)
A Polygenic Lipodystrophy Genetic Risk Score Characterizes Risk Independent of BMI in the Diabetes Prevention Program (2019) (8)
Metabolism of alpha-glycerol phosphate in human adipose tissue in obesity. (1967) (8)
Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine alendronate, and testosterone. (2004) (8)
Genetically determined vitamin D levels and change in bone density during a weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial. (2018) (8)
Fructose--how worried should we be? (2008) (8)
Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study. (2021) (8)
DNA synthesis in human adipose tissue in vitro. I. Effect of serum and hormones. (1969) (8)
Obesity: Liraglutide—another weapon in the war against obesity? (2015) (8)
Intraventricular administration of enterostatin decreases food intake in baboons (1992) (8)
Molecular and cellular determinants of body weight regulation. (1996) (8)
Interaction of light and corticosterone on food intake and brown adipose tissue of the rat. (1985) (8)
Methods to maximize retention in weight loss studies. (1999) (8)
Effect of Pioglitazone on Energy Intake and Ghrelin in Diabetic Patients (2010) (8)
Ankle‐brachial index and inter‐artery blood pressure differences as predictors of cognitive function in overweight and obese older adults with diabetes: results from the Action for Health in Diabetes movement and memory study (2015) (7)
The science of food regulation: food intake, taste, nutrient partitioning and energy expenditure. (1992) (7)
The Thyroid: Physiology and treatment of disease (1979) (7)
Obesity and Health-Related Quality of Life (2014) (7)
Studies on Cardiac Glycogen in Normal and Thyroidectomized Rats.∗ (1967) (7)
Risk factors: The obesity paradox—an artifact of small sample size? (2009) (7)
Nutritional infertility: mismanagement in central neuropeptidergic and peripheral insulin-leptin signaling. (1998) (7)
Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program (DPP) Received for publication 3 January 2007 and accepted in revised form 7 March 2007. The Diabetes Prevention Program Research Group (2007) (7)
Effects of Thyroid Status and Adrenergic Blocking Drugs on Isoproterenol-Induced Enlargement of the Salivary Glands.∗ (1967) (7)
Behavioral Determinants of Obesity (2014) (7)
Acute effects of intracerebroventricular corticotrophin-releasing hormone (CRH) on macronutrient selection (1992) (7)
Effects of ether and pentobarbital anesthesia on thyroid function in the rat. (1977) (7)
Effect of propylthiouracil and methimazole on the oxygen comsumption of hypothyroid rats receiving thyroxine or triiodothyronine. (1967) (7)
In the clinic. Obesity. (2008) (7)
Weight changes in obese adults 6‐months after discontinuation of double‐blind zonisamide or placebo treatment (2014) (7)
Group report: what are the bio-behavioral determinants of body weight regulation? (1996) (7)
Dietary management of the metabolic syndrome – one size fits all? (2013) (7)
Improved yield of obese rats using a double coordinate system to locate the ventromedial or paraventricular nucleus (1993) (7)
Nutrition, genetics, and heart disease (1996) (7)
Stimulated C-peptide and glucose levels as metabolic criteria to use insulin treatment in adult-onset type II diabetes. (1996) (7)
Nocturnal growth hormone secretion does not affect diurnal variations in arginine and glucose-stimulated insulin secretion. (1991) (7)
Overnight suppression test with dexamethasone in Cushing's syndrome. (1968) (7)
Changes in individual plasma free fatty acids in obese females during fasting and refeeding. (1991) (7)
More Salt, Please (1998) (7)
Association Between Change in Accelerometer-Measured and Self-Reported Physical Activity and Cardiovascular Disease in the Look AHEAD Trial. (2022) (7)
Adolescent overweight may be tempting fate. (1992) (6)
Human obesity and some of its experimental counterparts. (1979) (6)
Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study. (2020) (6)
Adrenalectomy in the Zucker fatty rat: effect on m-RNA for malic enzyme and glyceraldehyde 3-phosphate dehydrogenase. (1991) (6)
Summary of the dietary approaches to stop hypertension (dash) randomized clinical trial (1999) (6)
Genetic Susceptibility, Dietary Protein Intake, and Changes of Blood Pressure: The POUNDS Lost Trial. (2019) (6)
Triiodothyronine increases calcium loss in a bed rest antigravity model for space flight. (2008) (6)
Obesity and surgery for a chronic disease. (1996) (6)
The association of plasma lipids and vitamin K-dependent coagulation factors. (1996) (6)
Obesity research and medical journalism. (1995) (6)
Current Theories Regarding the Influence of Diet and the Control of Obesity (2001) (6)
Relationship between uptake of norepinephrine by hypothalamic homogenates and the activity of brown adipose tissue (1990) (6)
Energy expenditure using doubly labeled water: the unveiling of objective truth. (1997) (6)
Predicting Weight Loss Using Psychological and Behavioral Factors: The POUNDSLOST Trial. (2019) (6)
Obesity in perspective : a conference sponsored by the John E. Fogarty International Center for Advanced Study in the Health Sciences, National Institutes of Health, Bethesda, Maryland, October 1-3, 1973 (1973) (6)
Intestinal Bypass Surgery for Obese Patients: Behavioral and Metabolic Considerations (1978) (6)
Hereditary adiposity in mice: human lessons from the yellow and obese (OB/OB) mice. (1996) (6)
Regional fat loss from the thigh in obese women after adrenergic modulation. (1987) (6)
Effects of dexamethasone on glucose transport by skeletal muscles of obese (ob/ob) mice. (1989) (5)
Diabetes and Obesity—Time Bombs to Be Defused (2015) (5)
Effect of a meal on the oxygen consumption-heart rate relationship. (1981) (5)
Commentary on classics in obesity. 1. Quetelet: quantitative medicine. (1994) (5)
Plasma fatty acyl-carnitines during 8 weeks of overfeeding: relation to diet energy expenditure and body composition: the PROOF study. (2018) (5)
Body weight and blood pressure. (2012) (5)
Oxygen consumption of genetically obese rats (1969) (5)
Effect of adrenalectomy on the pancreas of db/db mice. (1986) (5)
Sugar consumption by Americans and obesity are both too high – are they connected? (2014) (5)
The Nutrient Balance Approach To Obesity (1993) (5)
Pituitary-ACTH response to metopirone and endotoxin administration in the dog. (1963) (5)
Comprar Handbook of Obesity: Clinical Applications, Third Edition | Claude Bouchard | 9781420051445 | Informa Healthcare (2008) (5)
Weight Gain Induced by Psychotropic Drugs (2007) (5)
Factors affecting basal metabolic rate. (1977) (5)
Dietary guidelines: The shape of things to come (1980) (5)
History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial (2020) (5)
Experimental obesity in man. VI. The effect of variations in intake of carbohydrate on carbohydrate, lipid, and cortisol metabolism. (1974) (5)
The control of food intake: effects of dieting and intestinal bypass. (1979) (5)
Physiological control of energy balance. (1980) (5)
Handbook of Obesity : Etiology and Pathophysiology, Second Edition (2003) (5)
Dietary Protein and Weight Gain—Reply (2012) (5)
Lavoisier and scientific revolution: the oxygen theory displaces air, fire, earth, and water. (1994) (5)
Genetic variation in lean body mass, changes of appetite and weight loss in response to diet interventions: The POUNDS Lost trial (2020) (5)
Is Sugar Addictive? (2016) (5)
Editorials: Is obesity a surgical disease? (1975) (5)
Distinct genetic subtypes of adiposity and glycemic changes in response to weight-loss diet intervention: the POUNDS Lost trial (2020) (4)
Body weight dynamics following intentional weight loss and physical performance: the Look AHEAD Movement and Memory Study (2015) (4)
Fat, follicles, and fecundity: the ruminant paradigm. (1998) (4)
In vitro fertilization and early embryo development. (1998) (4)
Is There Something Special about Low-Carbohydrate Diets? (2005) (4)
The pain of weight gain: self-experimentation with overfeeding. (2019) (4)
Self-Reported Gastrointestinal Symptoms in Type 2 Diabetes Improve With an Intensive Lifestyle Intervention: Results From the Action for Health in Diabetes (Look AHEAD) Clinical Trial (2015) (4)
Drug treatment of obesity. (2005) (4)
Starch Digestion–Related Amylase Genetic Variants, Diet, and Changes in Adiposity: Analyses in Prospective Cohort Studies and a Randomized Dietary Intervention (2020) (4)
Commentary on Banting letters. (1993) (4)
Effects of clenbuterol, a β 2-Adrenoceptor agonist, on Macronutrient selection in rats (1994) (4)
Triiodothyronine and mercurial diuretics. Effects on excretion of a water load and on plasma free fatty acids in obese patients. (1969) (4)
A retrospective view of obesity. (1992) (4)
Metabolic and behavioral differences between dieting and intestinal bypass. (1979) (4)
Body Fat Distribution and the Distribution of Scientific Knowledge (1996) (4)
Obesity: Maintenance of weight loss: setting our goals higher (2010) (4)
EFFECTS OF RESERPINE ON THYROIDECTOMIZED-ANDRENODEMEDULLATED RATS. (1964) (4)
Founding of the International Journal of Obesity: a journey in medical journalism (2014) (4)
Sympathetic Nervous System and a Nutrient Balance Model of Food Intake (1988) (4)
Weight-Loss Drugs (2007) (4)
Effects of oral and parenteral quinine on rats with ventromedial hypothalamic knife-cut obesity. (1984) (4)
Adipose tissue metabolism in six week old fatty rats. (1973) (4)
Epidemiology, etiology, and physiopathology (2014) (4)
Body weight and gonadotropin secretion in normal women and women with reproductive abnormalities. (1998) (4)
Sympathetic nervous system, adrenergic receptors, and obesity. (1999) (4)
Obesity: Is there effective treatment? (2002) (4)
Effect of ACTH on cardiac glycogen. (1966) (4)
Endocrine disturbances and reduced sympathetic activity in the development of obesity. (1990) (4)
Animal models of the aging-associated metabolic syndrome of obesity. (1996) (4)
Eat slowly--from laboratory to clinic; behavioral control of eating. (1996) (3)
Complications of oral contraceptive agents: a symposium. (1975) (3)
Experimental models for the study of obesity: introductory remarks. (1977) (3)
Animal models of hyperphagia. (1996) (3)
DNA synthesis in human adipose tissue in vitro. II. Effect of obesity. (1969) (3)
Some historical aspects of drug treatment for obesity (2008) (3)
Low-Fat vs Low-Carbohydrate Diets and Weight Loss. (2018) (3)
Sodium and blood pressure: no data dredging, please! (2003) (3)
Harvey Cushing and the neuroendocrinology of obesity. (1994) (3)
Medical Approaches to Treatment of the Obese Patient (2006) (3)
Reply to JQ Purnell, RH Knopp, and JD Brunzell (1999) (3)
OA02.01. Effect of macronutrient composition of weight loss diets on reduction of the inflammatory marker hsCRP (2012) (3)
Comprar A guide to obesity and the metabolic syndrome. Origins and treatment | G. Bray | 9781439814574 | CRC PRESS (2011) (3)
Commentary on Atwater classic. (1993) (3)
Effects of hypothalamic injection of corticotropin-releasing hormone (CRH) on electrophysiological sympathetic nerve activity to interscapular brown adipose tissue (IBAT) and feeding behavior (1989) (3)
Leptin and its actions on reproduction. (1998) (3)
Fiber Intake, Dietary Energy Density, and Diet‐Type Predict 6‐Month Weight‐Loss in Free‐Living Adults Who Adhered to Prescribed Macronutrient and Energy Composition of Varying Diets (2017) (3)
Obesity: a failure of homeostasis because of hedonic rewards: response to the letter from Gary Taubes (2009) (3)
Is There an Ideal Diet? (2019) (3)
Diet and exercise for weight loss. (2012) (3)
Growth of a molecular base for feeding: the mind body dualism. (1997) (3)
DIETARY FAT AND OBESITY. AUTHORS' REPLIES (1999) (3)
Changes of Branched-Chain Amino Acids and Ectopic Fat in Response to Weight-loss Diets: the POUNDS Lost Trial. (2020) (3)
Insulin secretion in hypothalamic obesity: diurnal variation and the effect of naloxone. (1993) (3)
A Review of Obesity (2002) (3)
Fetal alcohol abuse syndrome: nutritional considerations. (1998) (3)
Methods and obesity research: the radioimmunoassay of insulin. (1996) (3)
The Zucker-fatty rat: a review [Obesity] (1977) (3)
A case for drug treatment of obesity. (1994) (3)
Weight Gain and Intestinal Histology of Rats Fed Cholic, Lithocholic, Hyodeoxycholic, Chenodeoxycholic, and Deoxycholic Acids∗ (1969) (3)
There's More Than One Way to Skin A Cat: Response to “Reporting Weight Loss: Is Simple Better?” (2010) (3)
Obesity Has Always Been with Us: A Historical Introduction (2014) (3)
The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS) (2022) (3)
Obesity Is a Major Health Problem: Causes and Natural History (2006) (3)
Group report: what are the animal and human models for the study of regulation of body weight and what are their respective strengths and limitations? (1996) (3)
Interaction between dietary fat and exercise on excess postexercise oxygen consumption. (2014) (3)
Changes in bile acid subtypes and long‐term successful weight‐loss in response to weight‐loss diets: The POUNDS lost trial (2021) (3)
Temporal and mediation relations of weight loss, and changes in insulin resistance and blood pressure in response to 2-year weight-loss diet interventions: the POUNDS Lost trial (2021) (3)
Hypothalamic control of gonadotropin secretion: a role for leptin. (1998) (3)
Successful strategies for recruiting African Americans to prevention trials (1998) (3)
Dietary regulation of plasma lipid concentrations in the mouse. (1996) (3)
Blood DNA methylation at TXNIP and glycemic changes in response to weight-loss diet interventions: the POUNDS Lost Trial (2021) (3)
Let's treat obesity seriously. (2010) (2)
Surgical treatment of morbid obesity. (1979) (2)
Obesity in America (2018) (2)
Abstract P183: FTO Genotype, Dietary Protein, and Change in Appetite: the Pounds Lost trial (2014) (2)
Reply to R Sichieri (2000) (2)
DIET AND OBESITY (1935) (2)
Body fat distribution and the distribution and the distribution of scientific knowledge. (1996) (2)
Olfactory bulbectomy impairs the feeding response to 2-deoxy-d-glucose in rats (2011) (2)
Obesity, towards a molecular approach : proceedings of a UCLA Symposium held at Keystone, Colorado, April 17-23, 1989 (1990) (2)
Letters to the editor: an editorial. (1994) (2)
Prevention of Obesity (2016) (2)
Cannabinoid Receptor Antagonists as Potential Antiobesity Agents (2008) (2)
Effect of potassium depletion on distribution of urea and thiourea-C-14 in rat kidney. (1963) (2)
Effect of a Long-Term Behavioral Weight Loss Intervention on Nephropathy in Overweight or Obese Adults with Type 2 Diabetes: the Look AHEAD Randomized Clinical Trial (2015) (2)
Apolipoprotein E phenotypes and response to dietary fat and cholesterol. (1996) (2)
Chapter 10 – Drug Management in Obesity (2007) (2)
Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trial. (2020) (2)
“Brown‘’ Tissue and Metabolic Obesity (1982) (2)
Fiber Intake, Dietary Energy Density, and Adherence to Diet Assignment are Positively Associated with Weight‐Loss in Free‐Living Adults Consuming Calorie‐Restricted Diets at 6‐Month Follow‐Up: The POUNDS LOST Study (2017) (2)
Epidemics of Obesity and Metabolic Disorders: Are Dietary Fats or Sugars Involved? (2007) (2)
Measurement of body composition: an improving art. (1995) (2)
Costs, Pathology, and Health Risks of Obesity and the Metabolic Syndrome (2007) (2)
Proceedings of the 2nd International Congress on Obesity (1979) (2)
Models of nutrient partitioning. (1996) (2)
Abstract 14459: Changes in Gut Microbiota Metabolites and Successful Weight-loss in Response to Weight-Loss Diets: The POUNDS Lost Trial (2017) (2)
Extended-release fluvastatin 80 mg shows greater efficacy, with comparable tolerability, versus immediate-release fluvastatin 40 mg for once daily treatment of primary hypercholesterolaemia (2002) (2)
D010: Genetic determinants of bp response to dash dietary patterns (2000) (2)
The 20 most significant advances in obesity research, prevention and treatment. Foreword. (2008) (2)
Low-fat/high-fiber diets and coagulation/fibrinolysis. (1996) (2)
Disease Risk Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular (2013) (2)
Archeology of mind--obesity and psychoanalysis. (1997) (2)
Genetic Determinant for Amino Acid Metabolites and Changes in Body Weight and Insulin Resistance in Response to Weight-Loss Diets: The POUNDS LOST Trial (2013) (1)
Etiology and Prevalence of Obesity (2020) (1)
Weight loss, adherence, and dietary intakes of free-living adults consuming calorie-restricted diets varying in macronutrient composition: the POUNDS LOST Study (2020) (1)
Commentary on classics in obesity. 6. Science and politics of hunger. (1993) (1)
HNF1A variant, energy-reduced diets and insulin resistance improvement during weight loss: the POUNDS Lost and DIRECT trials. (2018) (1)
Obesity. A bibliography, 1974–1979, Anne Smith (Ed.). Information Retrieval Ltd., London, Washington DC (1980), 340, Compiled and edited by, with editorial advice from J. S. Garrow and J. T. Silverstone, Π22·50; $55·00 (1981) (1)
Weight management and exercise: any advantage? (2016) (1)
Medications for Obesity (2011) (1)
Evaluation of the Overweight and Obese Patient (2006) (1)
High fat diet differentially regulates olfactory receptors in the duodenum of obesity‐prone and obesity‐resistant rats (2012) (1)
Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort (2015) (1)
Abstract 14483: Early Changes in Metabolomics Signature and Prediction of Long-Term Successful Weight-Loss: The POUNDS Lost Trial (2017) (1)
Obesity and thyroid hormone (1977) (1)
Commentary on classics in obesity. 5. Fat cell theory and units of knowledge. (1993) (1)
Abstract P150: Weight-Loss Diets and 2-Year Change of Circulating Amino Acids in Two Randomized Intervention Trials (2015) (1)
Enterostatin and other neuropeptides that affect food intake. (1998) (1)
Fasting and reproduction in non-human primates. (1998) (1)
Eight weeks of dietary overfeeding increases renal filtration rates in humans: implications for the pathogenesis of diabetic hyperfiltration (2015) (1)
The Healthy Beverage Guidelines: a tool to fight obesity (2006) (1)
Biochemical and Molecular Roles of Nutrients The Effects of a High Fat Diet on Leptin mRNA , Serum Leptin and the Response to Leptin Are Not Altered in a Rat Strain Susceptible to High Fat Diet-Induced Obesity 1 , 2 (1998) (1)
Anorexia nervosa and socio-economic status. (1997) (1)
Abstract 17844: Genetic Variant of Body Iron Metabolism Modifies Insulin Resistance and Cell Function Response to Weight-Loss Diets in a 2-Year Randomized Trial: the POUNDS LOST Trial (2012) (1)
Dietary patterns may modify central adiposity. (2009) (1)
Dietary Carbohydrate Restriction in the Management of NAFLD and Metabolic Syndrome (2017) (1)
Response to C Weaver et al (2006) (1)
Evaluation of the Obese Patient-Reply (1976) (1)
Herbal medications: do they have a place at the table? (2001) (1)
Dietary fat intake does affect obesity! 1–3 (1999) (1)
Commentary on paper by Chambers. (1993) (1)
More salt, please. The DASH Steering Committee. (1998) (1)
Circulating thrifty microRNA is related to insulin sensitivity, adiposity, and energy metabolism in adults with overweight and obesity: the POUNDS Lost trial. (2022) (1)
Pharmacological Management of Obesity (2005) (1)
Abstract 048: Changes In Bile Acid Metabolism, Circulating MicroRNA-34a, And Improvements In Lipid Profiles In Response To Weight-loss Diets: The Pounds Lost Trial (2022) (1)
Association of Intensive Lifestyle Intervention and Metformin with Frailty in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS) (2018) (1)
The Obesity Society is turning 40: A history of the early years (2021) (1)
%β3adrenergicagonist%Satiety (1998) (1)
EVIDENCE FOR HYPOTHALAMIC-PITUITARY DYSFUNCTION IN THE PRADER-WILLI SYNDROME (1974) (1)
Founding of OBESITY RESEARCH (1993) (1)
Diet and Blood Pressure: The High and Low of It (2010) (1)
Drugs That Modify Fat Absorption and Alter Metabolism (2014) (1)
Sibutramine, Phentermine, and Diethylpropion: Sympathomimetic Drugs in the Management of Obesity (2014) (1)
Malnutrition in late gestation. (1998) (1)
Obesity and the Risk for Type 2 Diabetes (2017) (1)
Where now for obesity research (2011) (1)
Models of insulin resistance and diabetes (1994) (1)
Genetic and regulatory aspects in obesity of animals and man. (1974) (1)
Fat consumption and factor VII. (1996) (1)
Candidate genes modulating the relationship of body fat to plasma lipid levels. (1996) (1)
Gut Microbiota Metabolites, Amino Acid Metabolites, and Improvements in Diabetes-Related Traits—The POUNDS Lost Trial (2018) (1)
Nutrition in the Humphrey tradition. (1979) (1)
Dietary monounsaturated fat and the development of coronary artery atherosclerosis in African green monkeys. (1996) (1)
Therapeutic Management of Obesity (2020) (1)
Changing of the Guard (1997) (1)
New compartment model analysis of lean-mass and fat-mass growth with overfeeding. (2016) (1)
Energy Density and Adherence as Predictors of Weight Loss in the POUNDS LOST Study (2015) (1)
Effect of Weight Loss and Triiodothyronine on Plasma Growth Hormone and Insulin in Obesity. (1969) (1)
OBESITY — LESSONS FROM EXPERIMENTAL MEDICINE (1984) (1)
Obesity and diabetes (2007) (1)
Definitions and Prevalence (2007) (1)
The tide shifts again: the ebb and flow of history. (1995) (1)
Corticosterone and obesity in genetically obese mice. Abstr. (1983) (1)
Pennington Biomedical Research Center. Philanthropy refocuses nutrition thinking. (1990) (1)
Abstract P181: Temporal Relationship Between Changes in Body Weight and Insulin Resistance and Its Impact on Blood Pressure in Response to 2-year Weight-loss Diet Interventions: the POUNDS Lost Trial (2017) (1)
NUTRITIONAL ASPECTS OF OBESITY (1981) (1)
F002: The dash (dietary approaches to stop hypertension) diet lowers blood lipids (2000) (1)
Fogarty Center Conference on Obesity (1974) (1)
Noradrenergic, serotonergic, antiepileptic, and herbal drugs. (2004) (1)
Handbook of Obesity, Two-Volume Set (2003) (1)
Polymorphism in the apolipoprotein (a) gene promoter region and atherosclerosis in the right coronary artery of young white males. (1996) (1)
In the Footsteps of Wilbur Olin Atwater: The Atwater Lecture for 2019. (2020) (1)
Update on vitamin A-related deaths in Assam (2004) (1)
Changing of the Guard and a Farewell to Medical Journalism (1997) (1)
Weighing up dietary patterns – Authors' reply (2016) (1)
How bad is fructose ? 1 , 2 (2007) (1)
Regulation of energy balance. (1985) (1)
Genetically determined SCFA concentration modifies the association of dietary fiber intake with changes in bone mineral density during weight loss: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. (2021) (1)
Nutrition in transition: A challenge to cooperation and coordination (1979) (1)
Temperature, food intake, and the internal milieu. (1997) (1)
Drugs Used Clinically to Reduce Body Weight (2010) (1)
Effect of Overeating Dietary Protein at Different Levels on Circulating Lipids and Liver Lipid: The PROOF Study (2020) (1)
Determinants of sedentary 24h energy expenditure : equations for energy prescription and adjustment in a respiratory chamber 1 – 3 (2014) (1)
Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention Program (DPP) The Diabetes Prevention Program Research Group (2007) (0)
90th Anniversary Commentary: Consumption of Sweetened Beverages Predicts the Occurrence of Type 2 Diabetes. (2018) (0)
Opiate receptors, food intake and obesity. Abstr. (1980) (0)
Abstract P020: Triglyceride-lowering Lipoprotein Lipase Gene Variants And Improvements In Lipids And Lipoprotein Subspecies Defined By Apolipoprotein C-iii: Pounds Lost Trial (2021) (0)
Weighing up dietary patterns Reply (2016) (0)
Reply to P Schrauwen et al (2000) (0)
LDL subclass pattern and apolipoprotein E isoform phenotype in lipoprotein response to a reduced-fat diet. (1996) (0)
Genetic, Metabolic and Social Origins of Obesity (2011) (0)
The Mediterranean Diet to Prevent Type 2 Diabetes and Cardiovascular Disease (2017) (0)
Effects of chlorpromazine on the blood pressure reactions of healthy subjects following mecholyl. (1958) (0)
Obesity and diabetes — health budget breakers (2001) (0)
Evaluation, Prevention, and Introduction to Treatment (2007) (0)
Abstract 12756: Mc4r Genotype and 2-Year Change in Appetite in Response to Weight-loss Diets: The Pounds Lost Trial (2014) (0)
Reviewers of Manuscripts and Books (1976) (0)
Amphetamine: the Janus of treatment for obesity. (1994) (0)
Books Received (2003) (0)
Erratum to “Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine, alendronate, and testosterone” [Archives of Clinical Neuropsychology, 2004, 19, 153–163] (2004) (0)
On the shoulders of giants. (1997) (0)
The effects of adrenalectomy and insulin on glucose uptake and glycogen synthetase activity by skeletal muscle in obese (ob/ob) mice. Abstr. (1983) (0)
Does interleukin-6 modulate the beta(3)-adrenergic suppression of feeding? (1999) (0)
Anthropometric assessment: height, weight, body mass index (adults). (2002) (0)
Genetically determined gut microbial abundance and 2-year changes in central adiposity and body composition: The POUNDS lost trial. (2021) (0)
Reply to J Bigaard et al (2004) (0)
Effects of Dietary Trans Fatty Acids on Cardiovascular Risk (2017) (0)
Step-Defined Physical Activity Is Associated With Weight Loss and Changes in Body Composition and Fat Distribution in Response to Diet Interventions: The POUNDS Lost Trial (2021) (0)
Metabolic Syndrome—Past and Future (2008) (0)
Anosmia impairs the feeding response to 2-deoxy-d-glucose in rats (2008) (0)
From very-low-energy diets to fasting and back. (1995) (0)
on changes in fat oxidation from a high-fat diet Influence of dietary fatty acid composition and exercise (2015) (0)
Abstract 18754: Genetic Predisposition to Coronary Artery Disease and Changes in Lipid Profile in Response to 2-year Weight-loss Diet Intervention: The Pounds Lost Trial (2015) (0)
Reply to RJ Kaplan (2006) (0)
Comprar Nutrition Guide for Physicians | Wilson, Ted | 9781603274302 | Springer (2009) (0)
Physical Activity and Exercise in the Obese (2007) (0)
Definition, Measurement and Prevalence (2011) (0)
Obesity and Its Management, 2nd ed., D. Craddock. Churchill Livingstone, Medical Division, Longman Inc., 72 Fifth Ave., New York, NY 10011 (1973), 205 pp., softcover, $9.00 (1975) (0)
Abstract 47: Weight-loss Diets, Adiponectin, and Changes of Cardiometabolic Risk in the 2-year Pounds Lost Trial (2016) (0)
Viewpoint Good Calories , Bad Calories by Gary Taubes ; New York : AA (2008) (0)
Handbook of Obesity, Fourth Edition - 2 Volume Set (2014) (0)
Energy Expenditure During The First 24 Hours Of Overfeeding With Low, Normal And High Protein Diets (2011) (0)
appropriate for female children and adolescents? Are basal metabolic rate prediction equations (2015) (0)
ANAPHYLAXIS FROM BEE STINGS (1932) (0)
[Experimental obesity in rats --neural mechanism and the possibility of humoral factor in the hypothalamic obesity-- (author's transl)]. (1979) (0)
Signalling in bodyweight homeostasis ’ Afferent signals regulating food intake (2000) (0)
Report from the CORE at Pennington Biomedical Research Center (2006) (0)
Diurnal and diet effects on serum and cerebrospinal fluid leptin levels in Osborne-Mendel and S5B/Pl rats (2001) (0)
WITHDRAWN: Stimulation of food intake by mu opioid agonists is blocked by NPY antagonists (2006) (0)
Surgery for Obesity (2011) (0)
Centrally administered QRFP-26 increases high fat intake in female rats (2010) (0)
Comprar The Metabolic Syndrome and Obesity | Bray, George A. | 9781588298027 | Springer (2008) (0)
Anne Smith Obesity. A bibliography, 1974–1979 (1981) (0)
John Stuart Garrow, MD, PhD, FRCP(E), FRCP (London) (1929‐2016) (2016) (0)
CHARACTERISTICS OF VENTILATORY CONTROL IN RESPONSE TO THE METABOLIC ACIDOSIS OF EXERCISE (1976) (0)
Thyroid function in the obese mouse. Abstr. (1976) (0)
The Obesity Society 2016 awards and grants (2017) (0)
Energy Balance Model and Sites of Drug Action in the Host (2009) (0)
Nutrient preference and dietary obesity (1994) (0)
Consequences of Obesity (2014) (0)
History, Definitions, and Prevalence (2014) (0)
Effects of Reserpine on Hepatic Glycogen and Plasma Free Fatty Acids of Thyroidectomized-Adrenodemedullated Rats.∗ (1966) (0)
Reply to Dr. Schauf (1971) (0)
Drug treatment of , 2 (2005) (0)
The Doctor’s Tool Kit: Pharmacotherapy for the Patient with Obesity (2015) (0)
Obesity, Treatment of (2004) (0)
Guidelines for nutrition and exercise during pregnancy. (1998) (0)
Abstract MP60: Changes in Gut Microbiota Metabolite TMAO Are Related to Changes in Hepatic and Visceral Fat in Weight-loss Diet Interventions: the POUNDS Lost Trial (2019) (0)
The regulation of retinoic acid receptor expression by retinoids in mouse embryos. (1998) (0)
Gastrin secretion after weight loss by dieting and intestinal bypasss surgery. (1979) (0)
Apolipoprotein A-IV genotype and the response to dietary cholesterol. (1996) (0)
Nail Lacquer Dermatitis (1941) (0)
Abstract P064: Weight Loss Induced by Healthy Diets Reduces Atherogenic Lipoproteins that Contain ApoC-III Independent of Dietary Macronutrient Content (2013) (0)
Abstract P243: Greater Healthful Dietary Variety and Changes in Adiposity Indicators During a Weight-Loss Intervention: The POUNDS Lost Trial (2015) (0)
Changes in fatty acid composition of plasma phospholipids in response to varying amounts of dietary n-3 and n-6 fatty acids in humans (1997) (0)
Metabolic and Endocrine Factors in Regulation of Nutrient Balance (1988) (0)
A Statement of the Nutrition Committee of the American Heart Association (2005) (0)
Saturated fatty acids and cholesterolemia in primates. (1996) (0)
Abstract P205: Long-term Changes in Microbiota-dependent Metabolite Trimethylamine N-oxide and Risks of Hypertension and Coronary Heart Disease, and Their Modulation by Diet: The Nurses' Health Study and the POUNDS Lost Trial (2020) (0)
Reply to NJ Krilanovich (2004) (0)
Contemporary Reviews in Cardiovascular Medicine Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk (2010) (0)
Realities in the treatment of obesity (2002) (0)
Future Research in Obesity (1988) (0)
AHA/ADA Scientific Statement (2015) (0)
Preference for a high fat diet, but not hyperphagia following activation of mu opioid receptors is blocked in AgRP knockout mice (2009) (0)
In Memoriam: Alan Howard, MA, PhD, FRIC (1929–2020): as I knew him (2020) (0)
The founding of Obesity Research/Obesity: A brief history (2022) (0)
New Trends In The Management of Obesity In The United States (1996) (0)
The 1987 Awards of the American Institute of Nutrition (1987) (0)
A common alteration in the LPL gene resulting in altered lipoprotein levels. (1996) (0)
Hypothalamic regulation of adrenal sympathetic nerve activity in response to 2-deoxy-d-glucose induced glucoprivation (1991) (0)
Genetic determinants of dietary responsiveness of LDL cholesterol: a review of three candidate gene loci. (1996) (0)
Obesity-prone rats are less sensitive to the satiating effects of exendin-4 than obesity-resistant rats (2008) (0)
Surgical Treatment of the Overweight Patient (2006) (0)
Abstract 56: DNA Methylation of Birthweight-Blood Pressure Genes and Changes of Blood Pressures in Response to Weight-Loss Diets (2023) (0)
Diet and Obesity / Preface / Introduction / Contents (1988) (0)
Measurement of Human Fat Cells by a New Technique. (1970) (0)
Abstract 14433: Dietary Protein Intake Modifies the Genetic Risk on Insulin Resistance in the Pounds Lost Trial (2016) (0)
Ketosis in Children (1944) (0)
Effects of Obesity on Health and Metabolism (2011) (0)
Controls of Food Intake and Energy Expenditure (1988) (0)
Maternal nutrition and fetal growth: the role of insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs). (1998) (0)
Effect of dietary fatty acids on human cholesterol synthesis. (1996) (0)
The War Diet Squad (2018) (0)
The Reported Dietary Fat Compostion of 9-12 Year Old Children in Southern Louisiana is Comparable to National Averages (1997) (0)
Surgical treatment of obesity: current status. (1977) (0)
Treatment of Obesity: Beneficial Effects on Comorbidities and Lifespan (2011) (0)
The Mediterranean Diet: A Healthy Dietary Plan (2022) (0)
Evaluation of the Overweight Patient (2015) (0)
Effect of carbohydrate refeeding on free fatty acids after a fast in obese diabetic and obese non-diabetic females. (1989) (0)
Nutritional Status: An Overview of Methods for Assessment (2022) (0)
Gut Microbiome : Its Relationship to Health and Its Modulation by Diet (2017) (0)
Activation of hypothalamic serotonin receptors reduced intake of dietary fat and protein but not carbohydrate. (1999) (0)
THE REDUCTION AND CONTROL OF BODY FAT MASS 121 Carbohydrate and Fiber (2006) (0)
Natural History of Obesity (2007) (0)
Establishing energy requirements for body weight maintenance: validation of an intake-balance method (2017) (0)
Dietary approaches to stop hypertension (DASH): Results and implications (1998) (0)
Progress in understanding the genetics of obesity : Symposium: Recent discoveries in genetic influences on obesity (1997) (0)
Etiology of obesity (2002) (0)
Recent Advances in Nutritional Sciences The Influence of Different Fats and Fatty Acids on Obesity , Insulin Resistance and Inflammation 1 (2002) (0)
Omega-3 and Omega-6 Fatty Acids* : Roles in Cardiometabolic Disease (2017) (0)
Biological Determinants of Obesity (2014) (0)
New developments in diabetes obesity and insulin resistance. (1973) (0)
Effectof an acute reductionin carbohydrateintakeon subsequentfood intakein healthymen 13 (2006) (0)
Prevention of Obesity in Childhood and Adolescence (2014) (0)
Surgical Treatment for the Overweight Patient (2007) (0)
Prevalence of Ketosis in Children (1944) (0)
Increasing Healthful Food Variety is Associated with Reduced Total and Food‐specific Cravings among Men in the POUNDS Lost Weight‐loss Trial (2015) (0)
edical Progress Obesity Part 11-Treatment (2004) (0)
Abstract MP25: Dietary Fat Intake, Mc4r Genotype and 2-Year Changes in Body Composition: The Pounds Lost Trial (2015) (0)
Neuropsychological and emotional changes during simulated space flight and microgravity with countermeasures (1999) (0)
Abstract P223: Starch Digestion Related Amylase Genotypes Affect 2-year Adiposity Changes in Response to Weight-loss Diets: The Pounds Lost Trial (2017) (0)
Overview: the role of diet in the prevention of heart disease. (1996) (0)
Comprar The Metabolic Syndrome: · Epidemiology, Clinical Treatment, and Underlying Mechanisms | Hansen, Barbara C. | 9781588297389 | Springer (2008) (0)
Frequency of consuming foods predicts changes in cravings for those foods during weight loss: The POUNDS Lost Study (2017) (0)
Obesity Research and the New Biology (1996) (0)
Peripheral leptin administration to ob/ob mice decreases the gene expression of hypothalamic mu opioid receptors (2009) (0)
Role of apolipoprotein A-IV and its polymorphisms for reverse cholesterol transport and coronary risk. (1996) (0)
Those Who Consume Diets Meeting the Acceptable Macronutrient Distribution Range for Carbohydrate Are More Likely to Meet Dietary Fiber Recommendations: The POUNDS LOST Study (P08-085-19) (2019) (0)
Nutrition and Cardiometabolic Health (2017) (0)
Effect of the apo E polymorphism on reverse cholesterol transport. (1996) (0)
Pharmacotherapy of Obesity (2005) (0)
How Do We Get Fat (2007) (0)
Origins of Obesity in the Scientific Era: AD 1500 to the Present (2011) (0)
Obesity and its effect on reproductive function. (1998) (0)
The intraovarian IGF-I hypothesis: a 1997 update. (1998) (0)
An approach to the problem of obesity. (1969) (0)
Nutritional origins of athletic amenorrhea. (1998) (0)
Abstract 47: Changes in Gut-microbial Metabolite L-carnitine and Improvements in Atherogenic Lipoprotein Metabolism in Overweight and Obese Individuals: The POUNDS Lost Trial (2020) (0)
Environmental, Social, and Cultural Determinants of Obesity (2014) (0)
JCL roundtable: Clinical management of individuals with obesity. (2014) (0)
Response to “The Way We Report Weight Loss” (2010) (0)
Abstract 125: Weight Loss Selectively Increases High-density Lipoprotein without apoC-III, a Subfraction with Protective Association Against Coronary Heart Disease. (2013) (0)
Postscript: Obesity in the Twenty-First Century (2011) (0)
Preventing diabetes: lessons learned from the diabetes prevention program and its follow-up. (2009) (0)
Obesity: Understanding and Achieving a Healthy Weight (2022) (0)
Energy expenditure and substrate oxidation predict changes in body fat in children 1 (cid:1) 3 (2006) (0)
Supplements Used in Weight Management (2006) (0)
Interaction of Dietary Protein and Energy Balance (2017) (0)
A Status of Drugs on the Horizon for Obesity and the Metabolic Syndrome—a Comprehensive Review 2005 (2006) (0)
5 Clinical evaluation of the obese patient (1999) (0)
BARRIERS TO TREATING OBESITY. AUTHOR'S REPLY (1991) (0)
Introduction: Obesity 2000 (2000) (0)
Safeway’s Approach to Healthcare Cost Cutting (2009) (0)
Drug Treatment of Obesity: The Argument in Favor (1995) (0)
Reply to RJ Hine and JS White (2008) (0)
APOA 5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention : the Pounds Lost Trial 1 – 3 (2012) (0)
Control of Weight: How Do We Get Fat? (2010) (0)
Abstract MP74: Hnf1a Variant, Energy-reduced Diets, Weight Loss and Insulin Resistance: The Pounds Lost and Direct Trials (2016) (0)
CD36 receptor expression on the tongue is differentially affected by high fat diet in obesity-prone and obesity-resistant rats (2010) (0)
Steroids and regional fat distribution. (1998) (0)
Conference report--obesity: new directions, June 27-29, 1998, Charleston, South Carolina. (1999) (0)
Author response for "Genetic variation of lean body mass, changes of appetite, and weight loss in response to diet interventions: the POUNDS Lost trial" (2020) (0)
1573-P: Branched-Chain Amino Acids, Dietary Protein, and Improvement in Hepatic Fat and Abdominal Fat Distribution in Weight-Loss Diet Intervention: The POUNDS Lost Trial (2019) (0)
Can We Predict Underreported Energy Intake And Evaluate Nutritional Status Accordingly (1995) (0)
Obesity, Determinants of: Genetic Aspects (2001) (0)
Vitamins and cancer prevention. (1992) (0)
Nutrition, endocrinology, and disease. (1995) (0)
Effects and Mechanisms of Fructose-Containing Sugars in the Pathophysiology of Metabolic Syndrome (2017) (0)
PTP1B: A molecular mediator of leptin resistance. (2007) (0)
Obesity Medications: Where Are We Headed? (2006) (0)
Cholesteryl ester transfer protein gene polymorphisms and high-density lipoprotein cholesterol. (1996) (0)
Obesity and cancer: clinical epidemiology (2014) (0)
TESTOSTERONE ATTENUATES THE ACCELERATED WHOLE BODY PROTEIN TURNOVER ASSOCIATED WITH PROLONGED BEDREST 1152 (1997) (0)
Abstract 9898: Weight Loss Decreases High Sensitivity C-Reactive Protein Irrespective of Dietary Composition (2011) (0)
Anthropometric Assessment: Stature, Weight, and the Body Mass Index in Adults (2007) (0)
Chronic Pulmonary Catarrh in Childhood (1944) (0)
Assessment of obesity and classification of patients: historical perspectives and current practice (2007) (0)
Patterns in achieved energy intake: a mathematical approach to assessing adherence (811.7) (2014) (0)
Cardiometabolic risk modification: current trends and emerging therapies. (2006) (0)
Pharmacologic Therapy of Obesity (1999) (0)
Should We Treat the Metabolic Syndrome or Its Components (2007) (0)
Origins of Obesity (2011) (0)
Abnormal Exercise Test or CVD History on Weight Loss or Fitness: the Look AHEAD Trial. (2020) (0)
DNA Methylation of Birthweight-Blood Pressure Genes and Changes of Blood Pressure in Response to Weight-Loss Diets in the POUNDS Lost Trial. (2023) (0)
Fenfluramine combination therapy for obesity: the appearance rate of aortic regurgitation on serial echoes parallels the incidence in a larger cohort population (1998) (0)
Changes in Gut-Microbiota-Related Metabolites and Long-Term Improvements in Lipoprotein Subspecies in Overweight and Obese Adults: The POUNDS Lost Trial (2021) (0)
Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers in the Diabetes Prevention Program (2020) (0)
Abstract MP35: Circulating MicroRNA-21 And Cardiovascular Risk Reduction In Response To Weight-loss Diets: The Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial (2022) (0)
Abstract 41: Comprehensive Plasma Metabolomic Risk Scores to Predict Incident Coronary Heart Disease Events (2023) (0)
Medical Treatment of Obesity and Weight Managment Issues in the Treatment of Obesity (2014) (0)
Changes in circulating bile acid subtypes in response to weight-loss diets are associated with improvements in glycemic status and insulin resistance: The POUNDS Lost trial. (2022) (0)
Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775]. (2017) (0)
1410-P: Changes in Circulating MicroRNA-193b and Long-Term Successful Weight Loss in Response to Dietary and Lifestyle Interventions: The POUNDS Lost and CENTRAL Trials (2022) (0)
Treatment of the Metabolic Syndrome with Weight Loss, Exercise, Hormones, and Surgery (2008) (0)
Can we reduce snack food intake? 1,2 (2009) (0)
Abstract P619: DNA Methylation at SREBF1 and Long-Term Changes in Body Composition: The POUNDS Lost Trial (2023) (0)
The indexing waltz. (1995) (0)
Anthropometric Assessment: Historical Perspectives (2007) (0)
Medications in the Treatment of the Patient With Obesity Mechanisms Underlying Drug Therapy for Obesity (2012) (0)
Alcohol consumption and diabetes risk in the Diabetes Prevention Program 1 – 4 (2009) (0)
A Systems Genetics Approach Identified GPD1L and its Molecular Mechanism for Obesity in Human Adipose Tissue (2017) (0)
553-P: Changes in Circulating Bile Acids and the Improvements in Glucose and Insulin Metabolism in Response to Weight-Loss Diets: The POUNDS Lost Trial (2022) (0)
FTO genotype and weight loss (2018) (0)
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance (2016) (0)
Sleep Disturbance, Changes in Energy Intake and Body Compositing During Weight Loss in the POUNDS LOST Trial. (2022) (0)
Abstract P119: Circulating microRNA-122 and Improvement in Cardiovascular Health in Response to Weight-Loss Diets: The Preventing Overweight Using Novel Dietary Strategies (Pounds Lost) Trial (2023) (0)
Changes in pedometer‐measured physical activity are associated with weight loss and changes in body composition and fat distribution in response to reduced‐energy diet interventions: The POUNDS Lost trial (2022) (0)
349-OR: ADA President's Select Abstract: Circulating Level of DNA Methylation Near CPT1A and Long-Term Changes in Triglycerides in Response to Diet Interventions: The POUNDS Lost Trial (2022) (0)
DNA methylation near CPT1A and changes in triglyceride-rich lipoproteins in response to weight-loss diet interventions. (2023) (0)
Prevention, Evaluation and Introduction to Treatment (2011) (0)
1169-P: Circulating MicroRNA-378a-5p and Improvement in Glucose Homeostasis in Response to Weight-Loss Diets: The Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) Trial (2022) (0)
Abstract MP30: Circulating MicroRNA-128-1 And Changes In Energy Metabolism And Insulin Sensitivity In Response To Weight Loss Diet Interventions: The Pounds Lost Trial (2022) (0)
Abstract 65: DNA Methylation at ABCG1 and Long-Term Changes in Adiposity in Response to Diet Interventions: The POUNDS Lost Trial (2023) (0)
Effects of dietary fats on plasma lipoprotein metabolism. (1996) (0)
Effect of 8 weeks of supervised overfeeding on eating attitudes and behaviors, eating disorder symptoms, and body image: Results from the PROOF and EAT studies. (2021) (0)
An enzymatic defect in genetic obesity. Lack of thyroid induced (na+ + k+)-atpase. Abstr. (1978) (0)
Abstract P028: Gut Microbiota-Related Metabolites and Long-Term Bone Health in Response to Weight-Loss Diets: The POUNDS Lost Trial (2019) (0)
Abstract P131: Changes In Bile Acid Subtypes And Improvements In Adiposity And Energy Metabolism In Response To Weight-loss Diets (2021) (0)
Lifestyle, Diet and Exercise: Cognitive Solutions (2011) (0)
253-OR: Plasma Ghrelin Changes and Successful Weight Loss in Patients with Obesity: The POUNDS Lost Trial (2021) (0)
A look at diets and other treatments for obesity. (1979) (0)

This paper list is powered by the following services:

Other Resources About George A. Bray

en.wikipedia.org

What Schools Are Affiliated With George A. Bray?

George A. Bray is affiliated with the following schools: